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GENERAL INTRODUCTION 
 
 
Statement of the Problem 
 
 
          Mycobacterium avium subspecies paratuberculosis (Map) is the causative agent of 
paratuberculosis (Johne‟s disease), a disease that is widely disseminated in domestic and 
free-range ruminants around the globe.  The worldwide prevalence is unknown, but in 
United States dairy herds has been estimated to be as high as 68% [1].  Map infection is 
usually acquired by neonatal calves during the first few days of life, yet development of 
clinical disease generally is not evident for several years due to a prolonged 
asymptomatic subclinical infection period.  This is a significant research problem to 
overcome when studying pathogenesis of Map, and thus far models to effectively study 
host immunopathology during the span from the initial infection to clinical disease have 
been elusive.  To address this challenge, a considerable amount of research has been 
directed at this disease, yet the pathogenesis of early and subclinical Map infection 
remains a key scientific knowledge gap.  The following dissertation project is directed 
towards understanding the immunopathology of early Map infection in young calves, and 
how the initial events following Map infection may relate to host mechanisms of 
resistance or progression of this devastating disease. 
 
Immunopathology of Map infection      
     The obligate intracellular bacterium Map is a pathogen of macrophages.  The 
virulence of Map (and other pathogenic mycobacteria) is largely considered to be due to 
its 1) evasion of macrophage-mediated bacterial killing and 2) attenuation of antigen 
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presentation to the immune system [2].  In light of this, most research efforts have 
focused on these two aspects of the host innate immune response.  Due to challenges 
associated with studying host anti-mycobacterial immunopathology during early Map 
infection in vivo, the main descriptions of innate immunology relevant to Map infection 
have been derived from experimental in vitro macrophage cell culture systems [3].  
Evasion of macrophage killing has been experimentally shown to occur primarily by 
prevention of macrophage activation as well as blockage of phagosome acidification and 
maturation [4].  It has been shown that macrophages possess the vast arsenal for killing of 
invading mycobacterial organisms, yet not all Map are killed and at least a subset of 
bacteria are able to persist and proliferate within subepithelial macrophages of the 
intestine [5].  Classical macrophage activation with killing of ingested bacteria is vital for 
host resistance to Map infection, and this is presumably mediated by interferon gamma 
(IFN) secreting CD4+ T cells [6].   
     Traditionally, macrophage function during Map infection has been most widely 
studied, but more recent efforts have revealed that development of an efficacious 
adaptive immune response against Map is also profoundly influenced by the dendritic cell 
(DC).  DCs have been recently described in cattle where as a pool of professional antigen 
presenting cells (APC) they are, as in humans, thought to play an essential role during 
initiation of host T cell immunity [7, 8].  In humans, development of effective cell-
mediated immunity is dependent on DCs [9, 10], and modulation of DC function by 
mycobacteria has been shown to inhibit this process [11].  The complete role of DCs in 
cattle continues to be elucidated; however Map has been recently shown to influence 
bovine DC maturation status and ultimately development of the adaptive immune 
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response [12, 13].  Further understanding the role of these important cells will be helpful 
for fully developing an inclusive model for understanding the pathogenesis of Map.     
 
The influence of gamma-delta ( T cells in host response to Map   
     The role of minor lymphocyte classes (natural killer (NK) and T cells) during the 
initial anti-mycobacterial immune response has recently received significant research 
attention.  This is because data from in vitro human studies has suggested that these cells 
can modulate macrophage killing or DC function either directly or via cytokine secretion 
which may ultimately lead to alteration of the adaptive immune response [14, 15].  This 
is a significant observation which may have profound implications in bovine 
immunology because compared to humans or mice, young cattle have significant 
numbers of  T cells circulating in their peripheral blood and tissues [16].  Correlation 
between human and animal model data is incomplete, but human and bovine  T cells 
have been shown to share some functional features.  Further, the in vivo responses of  
cells have yet to be fully explored in any species, and the young calf is an ideal model to 
employ in efforts to understand their effects during the anti-mycobacterial immune 
response [17]. 
     Ultimately it seems that interaction between invading mycobacterial pathogen and 
host cells at the infection site determines the course and outcome of infection [18, 19].  
The probability of successful control of Map infection is greatly enhanced by three 
specific features of the host response: 1) efficient bacterial killing by immune cells at the 
infection site, 2) initiation of efficient antigen presentation at the infection site which 
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eventually determines 3) development of a systemic adaptive T helper 1 (Th1) immune 
response.  
 
Modeling the early host immune response to Map in calves   
     Key knowledge gaps identified by Map researchers are due in part to difficulty 
associated with successfully modeling early Map infection in cattle [20, 21].  The most 
relevant data on host-pathogen interaction is best acquired using the natural host in 
research trials, but use of ruminants in conventional model systems for Map research is 
limited by the time required to maintain animals in containment facilities before they 
develop disease.  An in vivo bovine model which successfully recapitulates all phases of 
the infection has not yet been described and so in order to fully elucidate the 
immunopathology of the infection site and during subclinical Map infection in calves 
there is significant need for improved model efficacy [3].  Though a number of novel 
experimental model systems have recently been published [20, 22-24], additional work is 
needed.  Focusing our efforts on the localized infection site immune response to Map and 
how this influences the subsequent disease process is expected to shed considerable light 
on the pathogenesis of Map infection in ruminants. 
     This literature review will focus on components of both the innate and adaptive arms 
of the host immune response, with an emphasis on the immunobiology of the  T cell 
and how the interactions of these components may result in containment or progression 
of Map infection in the young bovine calf.   
 
 
5 
 
Specific Aims 
     The primary goal of these studies was to understand the initial immunopathologic 
events occurring at the Map infection site in calves, and how these events may ultimately 
result in containment of infection, development of subclinical infection or ultimately 
allow progression to chronic end-stage wasting syndrome of clinical Johne‟s disease.  To 
address this goal, we first adapted a young calf model of subcutaneous Map infection [25, 
26] in order to evaluate the cellular and molecular events at Map infection sites in cattle.  
Our central hypothesis for this set of studies was that  T lymphocyte subsets play a 
central role in shaping the immune response at early Map infection sites in young calves.  
To address this hypothesis, the following specific aims were set forth:  1) investigate 
recruitment of  T cell subsets to Map infection sites in context of morphologic lesion 
development (Chapter 2) and 2) understand the functional role of T lymphocytes 
including  T cell subsets recruited to Map infection sites (Chapter 3).  Finally, we were 
interested in the correlation of our observations from the subcutaneous Map model with 
the development of intestinal Map disease in calves.  As a result of the initial work, our 
final specific aim was 3) to develop an intestinal model for studying subclinical Map 
infection thereby allowing testing of findings of the earlier specific aims in the 
gastrointestinal tract of cattle (Chapter 4).   
 
Dissertation organization 
     This dissertation is organized in the alternative format with the first chapter being a 
general introduction and literature review (Chapter 1).  This is then followed by three 
individual manuscripts (Chapter 2-4), followed by general conclusions with references 
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cited at the end of each chapter.  Two manuscripts have been published in the 
International Journal of Experimental Pathology (Chapter 2) and Veterinary Pathology 
(Chapter 4).  The third manuscript has been prepared for submission to Veterinary 
Pathology (Chapter 3).   
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CHAPTER 1: LITERATURE REVIEW 
 
Immunology of Map infection in cattle 
 
     It is generally accepted that Map infection occurs primarily during the perinatal period 
when calves ingest an infectious dose of live bacteria from feces or colostrum.  The 
organism is likely endocytosed by microfold cells (M cells) of the dome epithelium or the 
epithelial cells themselves [1-3] overlying ileal Peyer‟s patches and subsequently 
delivered to subepithelial macrophages and dendritic cells [4].  Classically, there is 
development of an initial T helper type 1 (Th1) immune response mediated by interferon 
gamma (IFN-secreting CD4+ T cells.  Effective Th1 polarization of the host immune 
response is considered vital for controlling mycobacterial infections [5], and detection of 
Map-specific IFN has been successfully used diagnostically during natural Map 
infections of cattle [6].  Following initial infection, a lengthy (months to several years) 
subclinical period occurs prior to development of fatal clinical disease in a subset of 
animals.  In these individuals, clinical disease is characterized by development of 
progressive granulomatous enteritis, diarrhea and wasting which eventually leads to death 
of the host.  Transition to clinical disease is immunologically associated with a loss of 
Th1 dominance [7] and development of T helper 2 (Th2) dominance.  The Th2 response 
is characterized by high levels of interleukin (IL)-4 and IL-5-induced Map-specific 
immunoglobulin production, which serves as the basis for commercially available serum 
diagnostic assays during clinical phase of disease.  Accurate diagnosis during latent 
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disease is at best challenging [8], and typically requires the use of multiple testing 
strategies that can be difficult to interpret [9].   
 
Macrophages 
     The role of macrophages during anti-mycobacterial immunity can be divided into two 
consecutive phases of the host immune response.  During the acute response, 
macrophages are recruited to the Map infection site where they participate in 
phagocytosis and bacterial killing and as professional antigen presenting cells (APCs) 
they are capable of stimulating the adaptive immune response.  The acute phase of the 
inflammatory response ends with either resolution of the infection or progression to the 
chronic inflammatory phase which is characterized by macrophage-rich cellular 
infiltrates (granulomatous inflammation) at the infection site.   
     Map is primarily an infection of macrophages.  Experimental infection models in 
calves have not resulted in consistent colonization by Map of the distal small intestine as 
observed during late subclinical and clinical stages of natural disease [10].  As a 
consequence, studies evaluating in vivo macrophage function during Map infection are 
scarce [11-14] and most data regarding the early post-infection period of cattle are 
derived from experimental in vitro studies [15].  The intracellular survivability of Map 
(and other pathogenic mycobacteria) appears to be largely due to its 1) evasion of 
macrophage-mediated bacterial killing and 2) attenuation of antigen presentation to the 
immune system [16].  Avoidance of macrophage killing has been experimentally shown 
to occur by prevention of macrophage activation and by blockage of phagosome 
acidification [17], which provides an environment for pathogen survival and potentially 
12 
 
intracellular growth [18].  Macrophages possess the vast mechanistic arsenal for killing 
invading mycobacterial organisms [19] and many Map-infected animals appear to 
eliminate the infection.  However, not all invading organisms are killed and so a subset of 
Map persist and proliferate within subepithelial macrophages of the intestine and this 
ultimately results in disease progression through the subclinical and clinical phases [20].  
The in vivo mechanisms surrounding these transitions have not been fully examined.  It is 
however clear from in vitro studies that classical macrophage activation mediated 
primarily by IFN-secreting CD4+ T cells plays a key role in destruction of the ingested 
bacteria [21].   
     In the event that the acute response is incapable of effectively resolving the infection, 
a transition to chronic inflammation occurs.  Chronic granulomatous inflammation lies at 
the center of mycobacteria-associated immunopathology and is considered to play an 
integral role in mycobacterial containment [22, 23].  In fact, granuloma morphology in 
humans and animals has been strongly associated with disease progression and outcome 
[24, 25].  On one hand, morphologically diffuse lesions (granulomatous inflammation) 
are associated with Th2 dominance and typified by clinical intestinal Map infection of 
cattle.  These are considered to be dysfunctional lesions that fail to control pathogen 
proliferation.  Morphologically, these lesions are dense sheets of macrophages and 
lymphocytes lacking distinct organization or stratification of the inflammatory cells.  
There are generally large numbers of viable mycobacteria (multi-bacillary disease) 
present in diffuse granulomatous lesions, signifying the inability of the host to effectively 
limit mycobacterial viability and enhancing the potential for widespread dissemination.  
In contrast to diffuse lesions is the discrete caseating granuloma, which is associated with 
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Th1 dominance and considered the hallmark histologic feature of human and bovine 
tuberculosis where pathogen proliferation and spread is limited and disease is controlled.  
These lesions are highly organized aggregates of macrophages with central regions of 
caseous necrosis and mineralization.  The macrophages are cuffed by lymphocytes and 
the discrete nodules are typically encapsulated and separated from adjacent tissue by 
distinct bands of mature fibrous connective tissue.  These lesions are accompanied by low 
numbers of viable mycobacteria (pauci-bacillary disease), potentially signifying the 
effectiveness of the host to limit bacterial survival and replication.  Discrete granulomas 
are thought to contribute to host protection, most importantly by limiting dissemination 
of bacteria and restriction of tissue damage by shielding surrounding tissue from the 
chronic on-going inflammatory process [22].  Granuloma morphology and its potential 
role during mycobacterial disease has been well-studied in humans [26, 27] and cattle 
[28-30].  These studies have revealed that many other factors (lymphocytes, cytokines) 
also greatly influence the formation and maintenance of granuloma morphology and 
some of these factors are further discussed below.   
      
Dendritic cells 
     Though macrophage function during Map infection is most widely studied, more 
recent research efforts have revealed that development of an efficacious adaptive immune 
response against Map is profoundly influenced by the dendritic cell (DC).  Most 
commonly studied in humans and mice [31], DCs have been more recently described in 
cattle where as a pool of professional APCs they are also thought to play an essential role 
during initiation of host T cell immunity [32, 33].  DCs are derived from bone marrow 
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precursors, and exist in an immature state throughout the body.  Most notably DCs are 
present within organized (Peyer‟s patches) and unorganized (lamina propria of intestine) 
lymphoid tissue at mucosal sites where they serve as sentinels against incoming 
pathogens.  Immature resident DCs have high antigen-uptake capabilities and are thought 
to be the primary recipient of antigen from M cells of the distal small intestine.  
Following antigen uptake by pathogen recognition receptors (PRRs), DC‟s undergo 
dramatic phenotypic and functional changes that are characteristic of the maturation 
process [33].  Mature DCs have reduced phagocytic activity but now the cells upregulate 
chemokines (CCR7) that aid in migration from Peyer‟s patches and into the draining 
lymph nodes where they present processed antigen to naïve T lymphocytes via major 
histocompatibility complex (MHC) molecules.  By this mechanism, naïve T cells are 
primed and effector T cells are induced to differentiate; thus the development of effective 
T cell-mediated immunity is heavily dependent on DCs [34, 35].   
     In mice and humans, DCs function as initial host cells for mycobacteria and play an 
important role during mobilization of immunity during the early infection period [36].  
Similar results have also been found in cattle, where the initial Th1 priming is dependent 
on DCs because DCs are thought to be a primary source of the Th1-promoting cytokine 
IL-12 [37].  Following infection with Mycobacterium bovis (M bovis) or Bacillus 
Calmette-Guerin (BCG), bovine DCs contain greater numbers of bacteria compared to 
macrophages, and they stimulate more effective proliferation and IFN secretion by 
autologous CD4+ and CD8+ T lymphocytes.  Consistent with M tuberculosis-infected 
human and murine DCs, bovine DCs infected with M bovis in this study consistently 
upregulated CD40, CD80 and MHC molecules and the magnitude of these effects 
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appears to vary proportionally with the virulence of the infecting agent [37].  Not all DC-
mycobacteria interactions lead to strong enhancement of an effective cell mediated 
immune response however.  DCs of human or murine origin [38] and bovine origin [37] 
have also been shown to secrete other cytokines (such as IL-10) following mycobacterial 
infection, and this may serve a regulatory role, or to dampen the pro-inflammatory 
response.  For example, infection with M leprae has been shown to inhibit or suppress 
activation and maturation of human DC relative to M tuberculosis and M bovis [39].  In 
this same study, the authors reported that M leprae-infected DCs induced mixed Th1 and 
Th2 immune responses, and they concluded that this effect was probably an important 
determinant of the dramatic anergy of M leprae-specific cell-mediated immunity in 
human lepromatous patients [39].   
     These are important observations that are uniquely relevant for Map because the 
progressive stages of bovine Johne‟s disease share some histologic and immunologic 
features with M leprae-induced disease in human beings.  Though the target organ 
differs, late Map infection in cattle is characterized by a lack of Map-specific T cell-
mediated immune response coupled with development of diffuse granulomatous 
intestinal inflammation.  In a mouse model, the fibronectin attachment protein of Map 
has been shown to modulate the adaptive immune response to Map infection by inducing 
maturation and activation of DCs which then drives Th1 polarization [40].  The in vitro 
data from this study would suggest that Map is capable of driving effective Th1 polarized 
immune responses in vivo; however other reports do not support this hypothesis.  It was 
shown by Lei et al that bovine DCs harvested from subcutaneous diffuse granulomatous 
Map-induced lesions had significantly reduced expression of CD40, CD80 and CD86 
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genes compared to DCs harvested from distinct granulomas induced in the same calves 
by Map vaccine.  Further, DCs from Map granulomas in this study also displayed 
reduced ability to induce autologous CD4+ T cell proliferation [41].  Reduced phenotypic 
and functional maturation of monocyte-derived bovine DCs following Map infection was 
also demonstrated in an in vitro system [42].  Contrasting with the mouse model studies, 
results from these calf studies suggest that Map induces limited phenotypic and 
functional maturation of bovine DCs.  The role of DCs during Map infection of cattle is 
only beginning to be explored yet it seems evident that further defining their function is 
key to developing a model for understanding the pathogenesis of Map.  
      
Lymphocytes 
     Two distinct lineages of CD3+ lymphocytes expressing a heterodimeric T cell 
receptor (TCR) exist in most species.  The dominant CD3+ lymphocyte population of 
most species expresses  and  TCR chains while a smaller population (except in 
neonatal ruminants) expresses  and  TCR chains.  As they relate to pathogenesis of 
mycobacterial infections,  T cell biology is well understood and will be briefly 
reviewed; this will be followed by a more extensive comparative review of the less well-
understood and more recently discovered  T cells of humans, mice and cattle.   
      
      T lymphocytes 
     The role of major lymphocyte subsets ( T lymphocytes) during mycobacterial 
diseases in humans and animals is well described.   T lymphocytes can be traditionally 
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assigned into two T helper (Th) subsets based on their distinct patterns of cytokine 
secretion in response to antigenic stimulation.  Th1 cells are characterized by secretion of 
IL-2 and IFN but not IL-4 or IL-5 while Th2 cells are characterized by secretion of IL-4 
and IL-5 but not IL-2 or IFN [43].  Th1 cells tend to be mediators of macrophage 
activation and delayed-type (T cell mediated) hypersensitivity, whereas Th2 cells 
promote immunoglobulin production by B cells and immediate hypersensitivity reactions.  
Initially it was described that cytokine secretion patterns were mutually exclusive in that 
cytokines such as IL-12 promoted Th1 development while suppressing Th2 development 
and likewise IL-13 promoted Th2 development at the expense of the Th1 response.  In 
the time since the initial descriptions, variations have been described in a variety of 
natural disease conditions that defy the classically described Th1-Th2 axis [44]; however 
this traditional dichotomous immunologic model persists in the literature [43].  The host 
defense against mycobacterial agents also continues to be largely defined in this way so 
the terminology is utilized in this review.   
     In humans infected with M tuberculosis, activation of Th1 CD4+ lymphocytes with 
IFNproduction and macrophage activation are considered crucial for protection [45].  
Similarly, Th2 predominance with IL-4 production is associated with progressive or 
disseminated disease and the immunologic balance measured by Th1/Th2 ratio is directly 
correlated with the favorability of disease outcome [46].  As for many mycobacterial 
diseases (such as M leprae in humans), Map infection of cattle is associated with an 
initial Th1 mediated cellular response with Map-specific IFN production.  At some point 
during the subclinical phase of the infection, loss of systemic and local cell-mediated 
immune responses [7, 47] correlates with development of a strong Th2 response 
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characterized by high levels of Map-specific immunoglobulin [48] and development of 
clinical disease.  The cellular and molecular events surrounding and modulating these 
transitions during pathogenesis of Map infection in cattle remain incompletely 
characterized. 

 T lymphocytes 
     In this section, the known immunobiology of  T cells in humans and cattle will be 
described, compared and contrasted.  The data described herein are also summarized in 
table form (Table 1, Features of major subsets of human and bovine  T cells).  The  
TCR was serendipitously discovered and first described in humans in 1986 [49], and a 
few years later was first described in cattle [50].  The  T cells have thus been less well 
studied compared to their well-known  counterparts.  However, since their discovery 
the immunobiology of  T cells has been most studied in humans and mice and the data 
have indicated that these cells have a variety of functions during both innate and adaptive 
immunity.  To date, demonstrated or proposed functions of  T cells include granuloma 
formation or maintenance, direct cellular cytotoxicity, cytokine and chemokine secretion, 
modulation of macrophage function, modulation of T lymphocyte function, modulation 
of DC function, phagocytosis with antigen presentation/processing capability and 
immune surveillance or regulation.  Regardless of some key differences between species, 
a significant amount of recent data indicates several common themes of  T cell 
immunobiology that span the species barrier and thus there are substantial generalizations 
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which can be made regarding the function of these unique cells during infectious diseases 
or inflammatory processes.   
     Specialized anatomic distribution and phenotype:  Within lymphoid tissues,  T 
cells are considered to be a minor T lymphocyte population compared to the major T 
lymphocyte population.  In contrast,  T cells are enriched in many organs containing 
epithelia or at mucosal surfaces such as intestine, lung, skin or reproductive tract which 
seems to indicate a role for these cells during immune surveillance and antigen sampling 
as mucosal surfaces are constantly confronted with potential pathogens [51, 52].  In 
addition to epithelial sites,  T cells are also well represented among peripheral blood 
mononuclear cells.  In humans and mice  T cells can represent 1-10% of circulating T 
lymphocytes in adults [53], but notably in ruminants this can be as high as 40% in young 
calves but generally diminishes to 10-25% as the animals reach adulthood [54].   
     The genetic arrangement of the human  TCR has been studied.  As for  and  
genes,  and  genes have variable (V), joining (J) and constant (C) regions.  The  and  
genes also contain diversity (D) segments whereas  and  genes do not [55].  In humans, 
the ability to distinguish  T cell subsets based on surface marker expression has not 
been reported.  Rather, T cell subsets of humans are defined by their  and  gene 
segment usage and it has been noted that  T cells from different anatomic sites show 
preferential V gene expression suggesting that human  T cell subsets have distinct 
functional roles [56].  For example, the two major  T cell subsets in humans are V1+ 
and V2+ cells and distinctions in their distribution and function have been observed.  
V2+ cells predominate in peripheral blood circulation and have been shown to 
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significantly expand during a variety of infectious diseases including mycobacterial 
diseases [57].  In contrast, the V1+ subset is less frequently observed in the blood, but 
are the majority subset in tissues and they appear to have cytolytic properties and secrete 
Th1 cytokines upon activation [58, 59].  Specific known functions of  T cell subsets are 
further discussed in following sections of this dissertation.  Expression of other molecules 
(CD2, CD5, CD4, CD6, and CD8) on  T cells has also been described in humans, mice 
and cattle: key features in humans and bovine cells are summarized in table 1.  There is 
considerable interspecies variability suggesting that these molecules are less useful for 
defining functionally distinct subsets and there is currently no species-wide  T cell-
specific marker [60, 61]. 
     The  TCR of cattle has also been cloned and characterized, but little is known about 
how preferential gene segment usage correlates with tissue distribution or functionality in 
this species [62].  Cell surface expression of the cysteine-rich scavenger receptor 
molecule workshop cluster 1 (WC1) is specific for  T cells in ruminants; however both 
WC1- and WC1+ subsets of  T cells exist.  While the WC1 molecule has been most 
widely used to define bovine  T cell subsets, other molecules (GD3.1, GD3.5, GD3.8) 
have been described [63, 64], but their significance or function remains unknown.  
Homologous WC1-like genes have been found in sheep, goats, horses, mice, pigs and 
humans; however gene expression of WC1 appears to be limited to ruminants [65].  
Based on their expression of the WC1 molecule, bovine  T cells are subdivided into 
two categories.  The larger of these subsets has the phenotype WC1-CD2+CD3+ and is 
found primarily within splenic red pulp and the intestinal tract while the second subset 
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has the phenotype WC1+CD2-CD3+ is found predominantly in peripheral blood where 
they can constitute between 10-25% of the peripheral blood lymphocytes in adults and up 
to 40% or more in young calves [61].  As in humans, it is thought that both phenotypes 
represent functionally distinct  T cell subsets that preferentially home to different tissue 
localizations [61].  Though this concept in cattle has not been completely explored in 
vivo, Jutila et al have demonstrated that subsets of bovine  T cells differentially express 
genes associated with proliferation and inflammation indicating distinct functional 
differences [63, 64]. 
     There is compelling evidence to support the hypothesis that  T cells are innate cells 
during host defense.  The fact that  T cells are preferentially found at mucosal surfaces 
seems to indicate a role during immune surveillance and antigen sampling [60].  Two 
additional features fundamentally distinguish between  and  T cells.  First, in 
contrast to conventional  T cells, it is recognized that most  T cells do not express 
the CD4 or CD8 accessory molecules and thus there is no MHC class I or MHC class II 
restriction.  Second,  T cells do not recognize ligands processed from complex antigens 
by professional APCs but instead see unconventional antigens such as phosphorylated 
microbial metabolites or lipid [66].   
     Ligands:  The nature of ligands or potential ligands for  T cell subsets of humans or 
animals is poorly characterized, yet it is clear that these cells are capable of recognizing a 
broad range of molecules.  Responses of  T cells to mycobacteria have been described 
for several years [67] and both protein [68, 69] and nonprotein [70, 71] antigens have 
been shown to induce  T cell responses.  In humans, the majority of studies have 
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examined reactive patterns of the V2+ subset of  T cells, which are unique to primates 
and the dominant subset present in human peripheral blood.  V2+ cells recognize low 
molecular weight non-peptide phosphate-containing metabolites produced by a variety of 
bacterial pathogens including mycobacteria [72].  Variations or other important ligands 
for V2+ cells also include microbial byproducts such as negatively charged alkyl 
phosphate antigens [73] and positively charged alkylamine antigens [74].   It is notable 
that many of the putative microbial ligands described for human  T cells have 
autologous counterparts or endogenous metabolites of the mevalonate pathway (present 
in all higher eukaryotes and some bacteria) which are upregulated during periods of 
cellular stress suggesting that  T cells also function during non-infectious processes 
[75].  Specific ligands for human V1+ cells are even less well described.  Spada et al 
reported that V1+ cells directly recognized CD1c molecules, and recognition was TCR-
dependent but did not depend on presence of foreign lipid or glycolipid antigens [59].  
The authors observed that CD1c is expressed by DCs in granulomas induced by M leprae 
infection [76] and hypothesized that V1+ cells could be thus activated during initial 
mycobacterial infection.  Specific ligands for V1+ cells should be further investigated 
given the distinct tissue distribution and functions that have thus far been described for 
this subset of  T cells. 
     As in humans,  T cell ligands in cattle are not clearly defined and the data have been 
conflicting.  In cattle, the majority of studies have examined the reactive patterns of 
WC1+ cells, which represent the subset with greatest ease of access because they are 
dominant in the peripheral blood of young calves.  WC1+ cells from M bovis-infected 
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calves respond to both protein and nonprotein antigens of M bovis and in one study the 
authors concluded that mycobacterial proteins including the novel early secretory 
antigenic target of M tuberculosis (ESAT-6) were dominant [77].  The dominant human 
Vcell phosphoantigen ligand isopentenyl pyrophosphate (IPP) induced proliferation 
of WC1+ cells from M bovis-infected calves [77], but this antigen was not recognized by 
naïve bovine  T cells [78].  Vesosky et al also showed that WC1+ cells from healthy 
calves did respond to stimulation with live mycobacteria, mycobacterial cell wall and 
mycobacterial culture filtrate proteins [78].  This study further demonstrated that 
proteolytic digestion of the mycobacterial cell wall component did not affect the WC1+ 
cellular response, suggesting that naïve WC1+ cells recognize a proteolytically-resistant 
component of mycobacterial peptidoglycan.  In both humans and cattle, the interactions 
surrounding  T cell activation have largely been considered to be TCR-dependent but 
MHC-independent [71] although TCR-independent activation has also been shown [79].  
Recent work has also demonstrated that purified human and bovine  T cells can be 
directly activated by pathogen-associated molecular patterns (PAMPs) in the absence of 
antigen presenting cells [80], which may have significant implications for the innate role 
of  T cells.  In summary, though the specific ligands for bovine  T cells remain to be 
characterized, it is clear that these cells have the capacity to respond to mycobacterial 
antigens in both naïve and infected individuals.        
     Importance of IL-2:  The role of the T cell growth factor IL-2 in T cell proliferation 
is well known.  The initial encounter with specific antigen along with the appropriate co-
stimulatory signals (CD28 of T cell binding B7 of APC) induces the synthesis of IL-2 
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and the  chain of the IL-2 receptor (CD25).  Subsequent binding of IL-2 to its high-
affinity receptor then triggers progression through the cell cycle, proliferation and 
differentiation of naïve T cells [55].  Distinct from their  T cell counterparts, it has 
been known that  T cells produce minimal amounts of IL-2 upon activation, and thus 
the proliferative response of human  T cells after antigenic stimulation is dependent on 
CD4+ T cell secretion of IL-2 [81].  In cattle, the WC1+ subset of cells requires the 
addition of exogenous IL-2 for proliferation in response to Theileria annulata-infected 
monocytes, and stimulation with IL-2 alone induced a limited proliferative response [82].  
However, WC1+ cells of M bovis-infected calves showed strong proliferation and 
upregulation of CD25 but minimal IFN production after stimulation with M bovis sonic 
extract and IL-2 or with IL-2 alone [77, 83].  IL-2 is thus considered a required secondary 
signal for activation of  T cells which ultimately drives them to proliferation.   
     Effects on granuloma formation, maintenance:  The importance of the granuloma 
during pathogenesis of mycobacterial disease was previously reviewed in this 
dissertation.  The role of  T cells in controlling elimination or progression of 
mycobacterial disease by mediating the formation, generation and maintenance of the 
mycobacterial granulomas has been explored.  Few studies have investigated  T cells in 
human granulomatous lesions, and results have conflicted as one study reporting no 
increase [84] and another studied reporting elevated  T cells [85] within human lesions 
of sarcoidosis.  Mice generally are not considered appropriate models to study granuloma 
morphology because it is well recognized that mice lack both the highly stratified 
structures and the presence of central caseation necrosis that are prominent features in 
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human granulomas [86].  However, reduced granuloma formation has been demonstrated 
in a  TCR knockout mouse model of Map infection [87].  In cattle,  T cells have been 
evaluated in the context of mycobacterial granulomas; however the data here has also 
been somewhat conflicting.  Wangoo et al showed that late-stage lymph node granulomas 
from M bovis-infected calves had significantly greater numbers of WC1+ T cells 
compared to early stage lesions, and that the WC1+ cells were spatially distributed at the 
peripheral zone near the fibrotic capsule of late stage highly organized granulomas [88].  
In a separate study however, this group could not confirm distinct spatial relationships of 
the  T cells within the granulomatous lesions [89].  In contrast, Palmer et al 
demonstrated that the number of CD8+ T cells and WC1+ cells was high during early 
stage M bovis-induced lymph node granulomas but diminished over time as the 
granulomas became progressively morphologically advanced.  The data from this study 
suggested that loss of CD8+ and WC1+ cells during late stages correlates with failure of 
the immune system to control infection [30].  Bovine  T cells have also been observed 
infiltrating the non-progressive diffuse granulomatous lesions induced by subcutaneous 
Map inoculation in a calf model [90], but more studies are necessary to fully examine the 
role of  T cell subsets during lesion development.   
     Immediate effector function: cytotoxicity:  The described effector functions for 
subsets of  T cells are many.  Activated human V2+  T cells have broad cytotoxic 
activity mediated by different pathways.  In one study, V2+ cells were able to directly 
lyse infected macrophages and reduce intracellular bacterial numbers by the Fas/Fas 
ligand pathway [91].  Dieli et al showed that generation of perforin and granzyme by 
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V2+ cells also was able to reduce the viability of both extracellular and intracellular M 
tuberculosis [92, 93].  A study that specifically examined both major subsets of human  
T cells demonstrated broad in vitro cytotoxicity by V2+ cells, but importantly observed 
that V1+ cells also exhibited this capacity [94].  In cattle, cytotoxicity mediated by 
bovine natural killer (NK) cells reduces intracellular viability of M bovis [95]; however 
the evidence for  T cell-mediated cytotoxicity is less clear.  It has been suggested that 
cytotoxicity is a feature of bovine  T cells during bovine paratuberculosis [96, 97].  
However, other reports show that bovine peripheral blood derived and antigen-stimulated 
 T cells (WC1 phenotype not reported, but likely predominantly of the WC1+ subset) 
were unable to mediate upregulation of nitric oxide production and bacterial killing by 
Map-infected macrophages [98].  Recent data showed that WC1- cells were capable of 
expressing the natural cytotoxicity receptor CD335 (Nkp46) while producing the pro-
inflammatory cytokine IFN in vitro [99].  Additional experiments should be performed 
in order to further clarify and define the functional cytotoxicity of  T cell subsets in 
humans and cattle.     
     Immediate effector function: cytokine secretion:  It has been known for several 
years that a key mechanism by which T lymphocytes respond to infectious agents and 
mediate immune functions is secretion of specific patterns of cytokines.  Upon 
recognition of their ligands,  T cells are able to generate a range of pro-inflammatory 
cytokines or antimicrobial peptides [100] and by this mechanism are thought to provide 
an initial barrier until antigen-specific  T cells have been expanded.  Cytokine 
production by  T cell subsets has been analyzed at the gene and protein levels in 
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humans and cattle.  Microarray analysis of stimulated human V2+ cells has shown 
upregulation of pro-inflammatory genes such as tumor necrosis factor alpha (TNF, 
IFN, macrophage-colony stimulating factor, IL-17 and IL-21 [101, 102]; however 
secretion of some of these cytokine proteins by stimulated V2+ cells has not been 
confirmed.  Initial studies in humans showed that peripheral blood-derived  T cells 
rapidly expand and produce IFN in response to nonpeptide phosphate antigens [103].  
Wang et al demonstrated that human V2+ cells generate IFN and TNF as early as 2 
hours following exposure to the live bacterial product iso-butylamine.  An interesting 
observation in this study was that production of cytokines was cyclic and limited to 
periods of direct contact with live bacteria, suggesting that  T cells focus their 
resources at the infection site [104].  V2+ production of IFN and TNF was also 
confirmed by Wesch et al [105].  In contrast, V2+ cells from human peripheral blood 
can be driven towards IL-4 production under specific culture conditions [105].  
Depending on the physiologic or pathologic context, subsets of murine  T cells have 
also been shown to produce Th2 cytokines [106].  Still other studies have attributed the 
production of keratinocyte growth factor or connective tissue growth factor to  T cells, 
thus suggesting more specialized tissue repair functions to these cells [66].  Microarray 
data for human V1+ cells suggests that when stimulated, these cells upregulate cytokine 
genes that are considered important during regulatory functions such as IL-10 and IL-11 
[101, 102], but secretion of these cytokine proteins has not been confirmed.  Even though 
V1+ cells have been demonstrated in mycobacteria-induced lesions in humans [67], 
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specific functional roles for this subset remain unclear and this is an area that needs 
further investigation.   
     In cattle, evidence for cytokine secretion patterns by  T cell subsets is less clear and 
the data are often conflicting, which mostly likely reflects numerous experimental 
systems that are used.  In a fetal bovine-severe combined immunodeficient (SCID-bo) 
xenochimeric mouse model, WC1+ cells did not produce significant IFN, but were 
shown to be involved in recruitment of other cells to mycobacterial infection sites, though 
this role was incompletely characterized [107].  Depletion of WC1+  T cells from M 
bovis-infected calves was correlated with increased antigen-specific IL-4, reduced innate 
IFN, and reduced IgG2 antibody, which has been specifically associated with Th1 
cytokines in cattle [108].  These results support the hypothesis that WC1+ cells have a 
role in directing the Th1 bias of the immune response.  WC1+ cells from M bovis-
infected calves are induced to proliferate strongly in vitro by both ultrasonicated extracts 
of M bovis cultures and by crude culture filtrates of M bovis but produce minimal 
amounts of IFN, compared to CD4+ T cells from the same animals [83].  From this 
study, the authors suggested that WC1+ cells represent the major population of 
mycobacterially-responsive bovine  T cells, though this role remains to be precisely 
defined.  Vesosky et al demonstrated that while proliferation of bovine  T cells from 
healthy cattle could be induced by a variety of mycobacterial antigens, the requirements 
for IFN production by these cells was more stringent.  Specifically, purified WC1+ cells 
produced significant amount of IFN in response to a non-protein component of 
mycobacterial cell wall antigen only when antigen-presenting cells and exogenous IL-2 
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were added to the cultures [78].  Though it has been suggested by many, no published 
studies document the production of IL-4 or other Th2-like cytokines from bovine T 
cells, and bovine WC1+ cells are generally viewed as pro-inflammatory due to their 
production of IFNAs is true for V1+ cells in humans, specific functional roles for 
WC1- cells of cattle have not been described.  Direct response to PAMPs in the absence 
of APCs has been described for both human and bovine  T cells (discussed previously), 
and this is an area where further studies are necessary in order to clarify the role of these 
cells during the anti-mycobacterial immune response, particularly in healthy calves.   
         The role of  T cells in inducing Th1 immune responses has received the most 
attention; however more recently  T cells have been shown to also play a role during 
the Th17 response.  Th17 responses are defined by the production of IL-17, and are 
thought to play a critical role in inflammatory pathology (specifically neutrophil 
recruitment) or autoimmune diseases and appear to be particularly important at mucosal 
surfaces [109].  Production of IL-17 has been demonstrated by naïve  T cells in mice 
[110], and it has been proposed that  T cells initiate Th17 response by up-regulation of 
IL-6 and IL-8, which in turn enhances neutrophil chemotaxis during early bacterial 
infections [111].  Sutton et al recently demonstrated that murine  T cells express the IL-
23 receptor, the transcription factor RORT, IL-17, IL-21 and IL-22 in response to IL-1 
and IL-23 (all features of Th17 response), and that their cytokine production is 
independent of  TCR ligation [112].  This raises yet another question regarding the 
importance of and possible redundancy of the  TCR in mice.  Yet another intriguing 
possibility for this novel  T cell role during the early immunopathology of 
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mycobacterial disease has been proposed by Yoshida et al, when they recently reported 
that IL-17 is essential for granuloma formation in mice [113].  IL-17 production by  T 
cells has also recently been confirmed in humans [114], but has not yet been reported in 
other animal model systems and should be investigated specifically in the bovine model. 
     Specific effects on other cell types:  Given the patterns of antigen recognition by  
T cells, and the fact that they reside preferentially in mucosal surfaces lined by lymphoid 
tissue, it seems logical to assume that  T cells potentially exert influence on the 
development of the immune response.  Specific interactions between  T cells and other 
immune cells have recently been investigated.  The ability of  T cells to innately 
produce IFN during mycobacterial infection is particularly interesting in context of 
mycobacterial diseases.  As a major product of Th1 cells that further skews the immune 
response toward a Th1 phenotype, this has been postulated to be a mechanism that would 
account for initial Th1 phenotype priming and overall Th1 bias of the immune response 
[115].  It has been proposed that early IFN production at the site of infection could 
stimulate killing of bacteria by macrophages [116] and enhance antigen presentation by 
stimulation of infection site dendritic cells to mature and migrate to draining lymph nodes 
thus initiating adaptive T cell immunity [117].  The specific effects of human and bovine 
 T cells on mycobacteria-infected macrophages have briefly been explored and were 
previously discussed in the  T cell-mediated cytotoxicity section of this dissertation.  
The data are conflicting and this phenomenon should be further investigated, particularly 
in cattle.  The influence of  T cells on DC function has been more extensively explored.  
The importance of the effective T cell-mediated immune response during mycobacterial 
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infection simply cannot be overlooked, and the development of pathogen-specific IFN-
producing CD4+ T cells seems to be directly influenced by innate immune activation.  As 
the primary antigen presenting cells of the innate immune system, DCs are thus 
considered to be primary determinants of the efficacy of the T cell mediated immune 
response.  It is known that compared to antigen alone, the addition of exogenous 
IFNenhances the maturation of human DCs in vitro and the potency of the ensuing Th1 
immune response [118].  In light of data regarding the functional capacity of  T cells 
and DCs in separate studies, the dynamics of  T cell-DC interactions have been more 
closely examined [72].  Enhanced DC maturation has been documented in vitro following 
activation of phosphoantigen-specific V2+ [119] and CD1c-restricted V1+ [120] 
human  T cell subsets.  Upon  T cell activation, there was increased expression of 
CD86 on co-cultured DCs and enhanced IL-12 production by the DCs which ultimately 
resulted in improved priming of downstream T cell responses.  It is well known that 
immature DCs are induced to maturation by microbial antigens interacting with cell 
surface Toll-like receptors.  Leslie et al elegantly demonstrated that efficient Th1 
polarization of naïve CD4+ T cells is induced by CD1-restricted V1+ cell signals, and in 
contrast DCs matured by microbial stimuli alone (no V1+ cells) resulted in “exhausted” 
DCs that were unable to induce efficient Th1 polarization [120].  These are important 
observations for several reasons.  As previously mentioned the V1+ subset of T cells 
in humans are found predominantly in tissues and mucosal sites which makes these cells 
a prime candidate for affecting the adaptive immune response from the initial 
mycobacterial infection site.  The response described by Leslie et al was found to be 
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partially mediated by the cytokines TNF and IFNin a non antigen-specific manner 
[120].  Thus, unlike other innate cells which could potentially provide the initial cytokine 
signaling to induce maturation of DCs at infection sites, Vcells are uniquely 
positioned to function in this role due to its tissue distribution.  It has also been shown 
that fully mature DCs stimulate  T cells for sustained innate immune responses [119], 
and this interaction is thought to occur at sites of infection or in secondary lymphoid 
organs [117].  Other research groups have documented similar interactions of V2+ cells 
of humans [121-123] or murine  T cells [124] with DCs, and this appears to involve 
both cytokine- and cell contact-dependent mechanisms [117].  Still another mechanism 
by which  T cells influence the adaptive immune response is when DCs acquire, 
process and present fragments or residual particulate antigen following lysis of infected 
cells or direct pathogen killing by cytotoxic  T cells [117].   
     In contrast to the many research reports investigating the interactions of human  T 
cells with DCs, studies of the cellular interactions between bovine  T cells and DCs are 
few.  An early study demonstrated that Theileria annulata-infected monocytes induce 
bovine WC1+ cell proliferation in the presence of exogenous IL-2 [82].  In the only 
report to examine both  T cell subsets of cattle, this group also showed that neither 
WC1- nor WC1+ cells from cattle were stimulated to proliferate in response to allogeneic 
DCs [125].  These results contrast to CD4+ and CD8+ T cells from these calves, which 
were strongly induced to proliferate by DCs in this system.  Recent work by Price et al, 
examined reciprocal interactions between monocyte-derived DCs and WC1+ cells from 
M bovis-infected calves in an in vitro co-culture system [126].  In this study it was 
33 
 
demonstrated that WC1+ cells upregulated surface expression of MHC class II and CD25 
(IL-2 receptor) and generated significantly greater amounts of IFN when co-cultured 
with DC, and that the DCs reciprocally produced significantly greater amounts of IL-12 
when co-cultured with WC1+ cells.  It was also shown that IFN secretion by WC1+ 
cells in this system was abrogated when the cells were separated, indicating that this 
phenomenon is cell-contact dependent [126].  These results further suggest that in cattle, 
 T cells may play a role in the activation of MHC class II-restricted  T cells, and that 
T cells are able to provide the initial IFN burst that is required for full maturation of 
DCs.  It is important to observe that the cells used in this experiment were from M bovis-
infected animals.  Thus, while these observations may help to explain enhanced 
protection observed following BCG vaccination of neonatal calves and humans compared 
to adults [127], the ability of innate  T cells to function in this manner in a bovine 
system remains unknown.  The mechanisms by which  T cell subsets differentially 
mature DCs continues to be explored, and in vivo animal modeling systems for 
examining these interactions would be highly advantageous.   
     Memory function:  The capability of primate  T cells to mount a memory response 
after microbial infection has also been demonstrated [128].  In a macaque model of 
tuberculosis, the characteristic features of memory T cell response were demonstrated 
which included antigen-specific persistence and the rapid and prolonged recall response 
upon re-infection.  Interestingly in this study, the expansion of V2+ cells in the 
peripheral blood compartment was associated with clearance of detectable bacteremia, 
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which supports the hypothesis that antigen-specific  T cells play an important role in 
overall immune competence [129].   
     Other functions of  T cells:  Additional roles for  T cells have been described in 
a variety of experimental systems, which further challenge the paradigms regarding these 
unique cells.  The ability of  T cells to directly present antigen to  T cells was first 
demonstrated in cattle [130] and pigs [131].  Evaluation of gene expression and protein 
expression using CTLA-4 antibody, Collins et al first demonstrated that B7 molecules 
were widely expressed on the surface of  T cells.  They next showed that antigen-
primed but not freshly isolated WC1+ cells directly induced significant CD4+ T cell 
proliferation, suggesting that this function is acquired during  T cell maturation, 
activation or differentiation [130].  Similar results have been demonstrated in human 
V2+ and murine  T cells [132].  Rapid and transient expression of the lymph node 
homing chemokine CCR7 was demonstrated on human  T cells after ligation of the  
TCR [133].  The investigators then stimulated V2+ cells with the ligand isopentenyl 
pyrophosphate (IPP) and observed that V2+ cells expressed a repertoire of antigen 
presentation and co-stimulatory molecules indistinguishable from lipopolysaccharide 
(LPS)-stimulated DCs [134].  The antigen-stimulated V2+ cells were capable of 
processing and presenting soluble protein antigen and inducing proliferation and 
differentiation of autologous naïve CD4+ and CD8+ T cells, confirming the ability of 
these cells to acquire antigen presenting capabilities [134].  Brandes et al also 
demonstrated the antigen cross-presenting capabilities of human V2+ cells by showing 
that these cells could process soluble extra-cellular microbial or tumor antigens in the 
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context of MHC class I molecules to effector CD8+ T cells [135].  Importantly, it was 
shown that the  T cells were more efficient at antigen cross-presentation than monocyte 
derived DCs, but the lack of antigen presentation by resting  T cells also suggests that 
 T cells cannot serve as substitutes for DCs [134].  The authors noted that it is uncertain 
where in the body antigen presentation by  T cells occurs, and they speculated that a 
likely location could be at the site of microbial encounter (infection site) in peripheral 
tissues [135].  The importance of  T cells among other innate lymphocyte populations 
is further highlighted as Wu et al recently reported that human  T cells but not NK cells 
were capable of professional antigen-presentation functions [136].  Further exploration of 
these functions of  T cells in the context of anti-mycobacterial immunity in many 
different animal species are necessary, and development of animal models whereby the in 
vivo infection site responses of  T cells and their influence on development of the 
immune response would be advantageous.          
 
Modeling systems to study mycobacterial infections 
 
     In the previous discussion of the host immune response to mycobacterial pathogens, 
several key areas regarding  T cell immunobiology were identified that need further 
attention.  Appropriate selection of animal models used to study various features of 
immunobiology or pathology should be carefully made.  In the case of  T cells, inter-
species differences clearly exist between humans and various animal models; however 
significant similarities between humans and cattle warrant further evaluation of this 
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particular animal model.  Limitations such as difficulty obtaining appropriate tissues exist 
for many species, thus the study of human and cattle  T cell biology has been thus far 
largely limited to in vitro evaluation of peripheral blood-derived  T cells and the lack of 
studies evaluating other  T cells subsets (V1+ in humans, WC1- in cattle) is reflected 
in the literature.  This could represent a significant knowledge gap, because in both 
species, the minor  T cell subsets have been shown to have powerful local and 
downstream effector functions.  Thus, there is a pressing need for animal modeling 
systems which allow not only evaluation of multiple tissue-specific  T cell subsets, but 
also the ability to examine these cells in the context of infection site-specific 
immunopathology.  Unlike mice, cattle display a remarkable similarity with humans 
regarding immunopathology of mycobacterial diseases [137], and this coupled with 
readily-available  T cells make young calves an excellent model choice to study the 
pathogenesis of mycobacterial disease.   
     One of the most significant challenges associated with study of Map infection in cattle 
is the evolving immunopathologic events in infected individuals that transition in vivo 
from early infection into a lengthy subclinical infection and eventually in some animals 
to severe chronic progressive wasting and eventual death of the host.  To address these 
significant knowledge gaps, there has recently been significant interest in the 
development of appropriate models to study the pathogenesis of early Map infection in 
cattle [10, 138].  The host immune response to Map infection is typically studied locally 
in ileal tissue or systemically using peripheral blood cells during the late subclinical to 
clinical stages of Map infection [4, 139, 140], but few studies have evaluated the local 
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response during early or subclinical infection [13, 14].  These studies have revealed 
significant information about the immunopathology at the Map infection site, but more 
studies are needed.   
     Because the ultimate progression of mycobacterial disease is strongly influenced or 
determined by the events occurring at the level of the infection site [86], and recognizing 
the need for models of Map infection, we set out to design a series of studies to evaluate 
 T cell subset responses at Map infection sites which would ultimately lead to 
expanding our understanding of how these cells influence and shape the subsequent local 
and systemic immuno-pathologic response to Map infection, and how this may correlate 
to clearance, containment or progression of this disease in cattle.       
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Table 1. Features of major subsets of human and bovine  T cells 
 
 Human V1+ Bovine WC1- Human V2+ Bovine WC1+ 
Tissue 
Distribution 
∙most in spleen, 
epithelial tissues 
∙few in blood 
∙most in spleen, 
epithelial tissues 
∙few in blood 
∙most in 
peripheral blood 
∙most in peripheral 
blood 
CD3 ∙positive ∙positive ∙positive ∙positive 
WC1 ∙negative ∙negative ∙negative ∙positive 
CD2 ∙unknown 
 
∙most positive 
 
∙positive ∙most negative 
CD4 ∙negative ∙negative ∙negative ∙negative 
CD8 ∙most negative 
∙50% of splenic 
cells are CD8- 
∙Rest of splenic and 
blood cells are 
CD8+ 
∙most negative ∙most negative 
Ligands 
∙microbial lipids or 
glycolipids? 
∙CD1c (direct) 
∙unknown 
∙protein, non-
protein antigens 
∙phosphoantigens, 
alkylamines, 
stress-induced 
molecules, 
PAMPs 
∙protein, 
nonprotein antigen 
of M bovis 
∙PAMPs  
Known 
biological 
functions 
∙expand in blood 
during HIV, herpes 
and malaria 
infection 
∙cytotoxicity 
∙migrate to early 
inflammation sites 
∙cytotoxicity? 
∙expand in blood 
during M tb and 
Cryptococcus 
infection 
∙cytotoxicity 
∙expand in blood 
during M bovis 
infection 
∙granuloma 
formation 
∙cytoxicity? 
Cytokines 
produced 
∙IL10, IL11 (gene-
expression only) 
∙unknown 
∙IFN, TNF, 
IL17, CCR7, IL4 
∙IL21, IL2, M-
CSF (gene 
expression only)
∙IFN 
Effects on 
DCs 
∙induce maturation ∙unknown 
∙induce 
maturation 
∙induce maturation 
Effects on 
other T cells 
∙unknown ∙unknown 
∙present antigen 
to CD4+ and 
CD8+ cells 
∙present antigen to 
CD4+ cells 
Response to 
Mycobacteria 
∙M leprae ∙unknown 
∙M bovis, M 
tuberculosis 
∙M bovis, M avium 
paratuberculosis 
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 Abstract 
     The characteristic lesion in bovine tuberculosis is well-organized respiratory 
granulomas.  This is typically associated with a strong T-helper 1 (Th1) biased cell-
mediated immune response and eventual containment of the infection.  In bovine 
paratuberculosis, the classic lesion is unorganized granulomatous intestinal inflammation.  
Clinical paratuberculosis is associated with a T-helper 2 (Th2) biased humoral immune 
response and eventual death due to inability of the host to contain the infection.  Recent 
reports have suggested that gamma-delta  T cells play a significant role in granuloma 
development and/or maintenance during initial stages of infection and may influence the 
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subsequent adaptive immune response.  The objective of this study was to use an in vivo 
bovine model to evaluate  T cells during the early host immune response to 
mycobacterial infection.  We used immunofluorescent staining, hyperspectral 
microscopy, and computerized assisted morphometry to evaluate staining and distribution 
of  T cells during development of organized and unorganized granulomas. Our data 
suggests that bovine T cell subsets are differentially recruited to early infection sites, 
and may be instrumental during the initial anti-mycobacterial host immune response as 
well as for granuloma organization.   
 
Key words: bovine, gamma-delta T cells, granuloma, mycobacteria, paratuberculosis 
 
Introduction 
     The role of major T lymphocyte subsets is well documented in both tuberculous and 
non-tuberculous mycobacterial disease [1, 2]; however, recent studies in humans [3, 4], 
non-human primates [5] and cattle [6-9] have provided evidence that minor T cell 
populations including  T cells are also involved.  It is thought that  T cells play an 
early role during infection and provide a link between the innate and adaptive immune 
responses [10, 11].  It is known that  T cells differ widely between species and 
interspecies correlation of the data has not been reported; however, human and bovine  
T cells share some notable features including subset specific tissue distribution [12, 13] 
and proposed function [14, 15].  Human  T cell subsets are distinguished by germ-line 
gene segment usage and are thought to represent a heterogeneous population of cells 
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capable of serving immediate effector, tissue homing, recall or even memory functions 
[3, 16].  Bovine T cell subsets are differentiated by a unique workshop cluster 1 
(WC1) molecule which is a member of the scavenger receptor cysteine rich family and is 
expressed on the surface of 50-90% of peripheral blood  T cells [17].  Distinct isoforms 
of the WC1 molecule have been characterized [18-20], yet its exact function remains 
unknown.  Work by Jutila and colleagues has suggested that bovine WC1+  T cells 
have inflammatory characteristics while WC1- cells have a regulatory function [21, 22].  
A role for  T cells during antimycobacterial immunity is implied as WC1+  T cells 
from either infected or uninfected cattle proliferate and produce interferon (IFN)- when 
stimulated with M. bovis antigens [23, 24].  The importance of WC1+ T cells is further 
supported by studies showing modulation of the immune response in calves depleted of 
WC1+ T cells [25].  Evidence that T cells play a significant role at initial infection 
sites is less clear, but these cells are observed within mycobacteria-induced lesions of 
humans and cattle [16, 26, 27] and in lymph nodes draining mycobacterial infection sites 
of cattle [9, 28, 29].  A role for  T cells during granuloma development in mice or as 
early effectors during mycobacterial infection of humans and macaques is supported by 
recent reports [5, 30-32].       
     It is generally accepted that progression of mycobacterial disease is influenced at the 
level of the infection site and that survival of the host depends on the ability to limit 
mycobacterial proliferation through effective granuloma formation [33].  Well organized 
lesions correlate with longer host survival while unorganized lesions are associated with a 
poorer prognosis, and this suggests that the local host tissue response is indicative of a 
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patient‟s likely response to therapy and long-term survival [2, 34, 35].  A variety of in 
vivo and in vitro animal model systems have been utilized to further characterize the 
complex immunopathology of the infection site with variable success.  The murine model 
has limitations for understanding granuloma development and progression in response to 
mycobacterial infection [33].  The bovine is an attractive alternative model system [36], 
and cattle are natural hosts of tuberculous and non-tuberculous mycobacterial infections.   
     The goal of the current study was to evaluate  T cell subsets in mycobacterial 
granulomas to better understand the early role of these cells in host defense against 
infection.  A bovine subcutaneous model was employed to address two fundamental 
questions concerning the relationship of  T cells to the developing granuloma during 
mycobacterial infection.  First, we sought to identify differences in T cell recruitment 
into initial stages of organized vs. unorganized granulomas.  Second, we asked if the 
ability of an animal to initially generate an organized granuloma to Mycobacterium avium 
subspecies paratuberculosis (Map) antigens (killed bacterin vaccine) would translate into 
the development of an organized granuloma at a subsequent focus of Map infection.  Our 
data support the initial hypothesis that T cell subsets are differentially associated with 
organized and unorganized granulomatous lesions in the bovine.  Data from these 
experiments suggest that bovine  T cell subsets have different immune roles, and may 
be central regulators of both local and systemic antimycobacterial immune responses. 
 
Materials and methods 
     Animals and care.  Four- to six-week-old castrated male Holstein calves were used in 
the following experiments and were housed in isolation at the Iowa State University 
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College of Veterinary Medicine biosafety level II animal care facility.  A total of nine 
calves were used for this project and were maintained three at a time for handling 
purposes.  Animals were acquired from the Iowa State University dairy research farm 
(Ankeny, IA), a herd certified free of Map infection.  All live animal-related protocols 
were approved by the Committee on Animal Care and Use at Iowa State University.   
     Vaccine.  M. avium subspecies paratuberculosis bacterin (Mycopar®, Fort Dodge 
Animal Health, Fort Dodge, IA) was used in this experiment.  Mycopar is a commercially 
available whole-cell bacterin containing inactivated Mycobacterium paratuberculosis in 
oil.  Mycopar is known to generate a variably sized granuloma in vivo, and as such was 
used in these experiments as an example of a highly organized (tuberculoid-like) 
granuloma allowable in biosafety level II facilities.   
     Bacterial inoculum and infection.  The Map strain 19698 was obtained from the 
American Type Culture Collection (Manassas, VA) and maintained in Middlebrook 7H9 
broth supplemented with mycobactin J.  Logarithmic growth-phase bacteria were washed 
and resuspended in sterile saline for inoculation.  Bacterial concentration was determined 
by measuring absorbance at 540nm, comparing the absorbance optical density to the 
standard curve, and adjusted to a final concentration of 1 X 10
9 
CFU/mL in 0.9% sterile 
saline solution.   The Map inoculum used in these studies was shown to have greater than 
90% viability via fluorescein diacetate (FDA) staining and flow cytometry analysis prior 
to inoculation.  In addition, challenge inocula were confirmed negative for contaminants 
by streaking onto sheep blood agar plates 24 hours prior to injection.   
     Monoclonal antibodies and antigens.  The following mouse anti-bovine monoclonal 
antibodies were purchased from VMRD (Pullman, WA) and used to characterize  T 
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cells by multi-color fluorescent immunohistochemistry:  anti- TCR (GB21A), anti-
WC1(n1) (B7A1).  Alexa-fluor 555-conjugated goat anti-mouse IgG2b and Alexa-fluor 
488-conjugated goat anti-mouse IgM (Invitrogen Molecular Probes, Carlsbad CA) were 
used as secondary antibody conjugates.  DAPI nucleic acid stain (Invitrogen Molecular 
Probes) was used to stain nuclei.   
     Experimental Design.   For these experiments, a localized Map infection system 
developed in our laboratory was used with a few modifications [37, 38].  Calves were 
inoculated on day 0 of the experiment with either Map vaccine (n=6) or sterile saline 
(n=3) in the following manner:  Two hundred fifty (250) L was administered 
subcutaneously in three locations separated by 8-10cm in the left cervical region.  A 
single vaccine injection site nodule was surgically removed from each calf at three post-
inoculation time points designated early (7-10 days), middle (30 days) and late (greater 
than 60 days).     
     Calves were then inoculated with live Map sixty days following Mycopar or sham 
saline vaccination.  Each calf was subcutaneously inoculated with 5 X 10
8
 live Map in 
500L sterile saline in three locations separated by 8-10cm in the right cervical region.  
A Map infection site nodule was surgically removed from each calf at three post-
inoculation time points designated early (7-10 days), middle (30 days) and late (greater 
than 60 days).  All tissues were fixed for histopathology in 10% neutral-buffered formalin 
or snap-frozen for immunofluorescence in liquid Tissue-Tek Cryo-OCT compound 
(Fisher Scientific, Pittsburgh, PA) and stored at -80°C.   
     Scoring of hematoxylin and eosin stained lesions.  Formalin-fixed, paraffin-
embedded vaccine and infection site lesions were sectioned (4m) and stained with 
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hematoxylin and eosin (HE) for histologic evaluation and lesion scoring.  HE stained 
vaccine and infection site lesions were individually scored using a scoring system 
adapted from previous studies [9, 37, 39].  Scores of 0-3 were assigned for each 
parameter to reflect the degree and organization within each lesion.  A score of 0 
indicates absence of the parameter from the lesion (normal), while a score of 3 reflects 
both a significant presence (most severe) and a high degree of organization of the 
parameter within the lesion.  The following parameters were evaluated: fibrous 
connective tissue, macrophages, polymorphonuclear cells (neutrophils and eosinophils), 
small mononuclear cells (lymphocytes and plasma cells), multinucleated giant cells, 
necrosis, and mineralization.  Individual parameter scores were summated, and a single 
collective score was assigned for each lesion which reflected the histological organization 
and stage of development of each lesion.  Negative control sites (saline) lacked 
significant inflammatory components.   
     Immunofluorescent tissue staining.  OCT frozen sections were cut at 4m and fixed 
in 100% ice-cold ethanol.  Sections were washed once with phosphate-buffered saline 
(0.01 M PBS, pH 7.2), blocked for 30 minutes with 10% normal goat serum, then stained 
at 4°C overnight with a cocktail containing monoclonal antibodies for  TCR (1/10000) 
and WC1 (1/1000).  Slides were then washed twice with sterile PBS and stained for 45 
minutes at 20ºC sequentially with appropriate secondary conjugates (AF555 goat anti-
mouse IgG2b and AF488 goat anti-mouse IgM, 1/1000), prior to nuclei staining with 
DAPI (1/30000).  Following staining, slides were washed twice with sterile PBS, then 
mounted with anti-fade medium (4% n-propyl gallate (Sigma Aldrich, St. Louis, MO) in 
90% glycerol and 10% PBS) and cover-slipped.   
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Immunofluorescent hyperspectral microscopy.  Fluorescence image data was collected 
using an Optical Insights hyperspectral microscopy system composed of the Optical 
Insights (MAG Biosystems, Tucson, AZ) instrument attached to an inverted Nikon 
TE2000 microscope (Nikon, Melville, NY) equipped with a Photometrics Cascade 512B 
digital camera and Melange® software (Molecular Devices, Sunnyvale, CA).  All images 
were captured at 200X magnification (20X objective).   Fluorescence data were first 
collected from single-color (AF488, AF555 or DAPI) stained slides, and individual 
fluorescent spectra were defined.  Sample slides stained with all three fluorophores were 
then imaged.  Raw data was corrected for tissue autofluorescence, and hyperspectral 
unmixing was performed to extract individual spectra based on the previously defined 
parameters for each fluorescent spectra.     
     Computer-assisted morphometric analysis of immunofluorescent stained slides.   
Image analysis was performed using Metamorph 7.0 software (Molecular Devices).  
Briefly, multicolor images were separated based on their unmixed and corrected spectral 
profiles.  A visual threshold was applied to individual spectral profiles, and object 
definition was defined in pixels based on the scorer‟s (BLP) visual interpretation of a 
single positive cell.  Data from individual images was then collected and stored as the 
following parameters:  total cell count (DAPI positive nuclei per image), total  TCR 
positive cells (AF555-expressing cells) and total WC1 positive cells (AF488-expressing 
cells per image).   
     Statistical analysis.  Statistical analysis was performed using JMP 7.0.2 Statistical 
Discovery system (SAS Institute, Cary, NC).  Data are presented as the mean value ± 
standard error of the mean except where stated otherwise.  Student‟s t-test and one-way 
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analysis of variance were used for the statistical analysis.  Group mean differences were 
considered significant if the p value was <0.05. 
 
Results 
   Differential histopathology of subcutaneous granulomas.  To generate unorganized 
and organized granulomas we inoculated either live Map organisms or Map vaccine 
subcutaneously in calves.  Map inoculation site nodules reached a maximal size of 20-
25mm diameter approximately 7-10 days post injection and gradually resolved.  Map 
vaccine site nodules reached a maximal size of 30-50mm diameter approximately 20-30 
days post injection and generally remained grossly unchanged in size for the study 
duration (data not shown).  Histopathology observed at Map inoculation sites was similar 
to intestinal lesions of cattle with naturally occurring cases of Map infection (Johne‟s 
disease) and were characterized by an unorganized accumulation of macrophages with 
fewer lymphocytes and plasma cells.  The lesions did not exhibit significant histologic 
progression over time (Fig. 1A), and at later stages diffuse granulomatous lesions lacked 
fibrous tissue encapsulation, central necrosis and mineralization (Fig. 1B).  Initial lesions 
at Map vaccine sites were similar to infection sites; however in contrast to Map infection 
sites, they became highly organized over time (Fig. 1A, *p<0.0023).  Features of later 
stage granulomas included central coagulative to lytic cellular necrosis with variable 
degrees of mineralization surrounded by a dense rim of macrophages, giant cells and 
aggregates of lymphocytes and plasma cells.  The entire nodular structure was eventually 
rimmed by a band of mature dense fibrous tissue (Fig. 1C).  
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     T cell subsets in unorganized and highly organized granulomas.  We compared 
 T cell subsets during developing stages of highly organized and unorganized 
granulomatous lesions using immunofluorescence staining and computer assisted 
morphometry.  In unorganized lesions, the total number of recruited  T cells was 
significantly greater in late stages compared to early stages (Fig. 2A, *p=0.0002).  
Compared to unorganized lesions, highly organized granulomas contained significantly 
higher numbers of WC1+ cells during initial stages (Fig. 2B, *p=0.0062) and WC1- cells 
during later stages (Fig. 2C, **p=0.0017).   
     Spatial organization of T cell subsets in granulomas.  We evaluated spatial 
orientation and arrangement of  T cell subsets within developing granuloma subtypes.  
Early stages of all lesions lacked significant histologic organization, and both  subsets 
were distributed evenly and diffusely throughout these sections.  While the distribution of 
 T cell subsets remained diffuse over time in unorganized lesions, a distinct subset-
specific stratification pattern was observed as granulomas exhibited progressive 
histologic organization.  Specifically, the WC1+ subset was restricted to the outer 
margins of the granuloma near the fibrous border (Fig. 3A-D) while WC1- cells were 
heavily concentrated near central regions of the granuloma adjacent to the area of central 
cavitation and necrosis (Fig. 3A, E-G).   
     Histology of Map infection sites in naïve and vaccinated calves.  We next set out to 
answer the question “if calves initially produce a well-organized granuloma to Map 
vaccine, will they subsequently generate a highly organized granuloma to Map infection 
at a distant subcutaneous site?”  We compared the histology of early and late Map 
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infection sites in naïve calves to those in previously vaccinated calves.  Regardless of the 
vaccination history of the animals, granulomas at Map infection sites did not achieve the 
same level of organization as the vaccine sites (Fig 1A).  Nevertheless, we did find that at 
later time points, Map infection sites in vaccinated calves had significantly higher 
histologic scores compared to Map infection sites in naive calves (Figs. 4A, *p=0.0449).  
We examined the lesions to determine which parameter(s) of our scoring rubric 
(macrophages, lymphocytes, giant cells, fibrous tissue, necrosis and mineralization) 
accounted for differences observed.  Late stage Map infection sites of vaccinated calves 
contained prominent large Langhans-type multinucleated giant cells (Fig. 4B 
arrowheads), mildly increased fibrosis (Fig. 4B, arrow) and random small foci of 
necrosis.  These parameters were not significant morphologic features of Map infection 
sites at any time point in naïve animals. 
      T cell subsets in Map infection sites of naïve and vaccinated calves.  
Considering the effect of vaccination on Map granuloma morphology we were interested 
to know if vaccination influenced recruitment of  T cell subsets to Map infection sites.  
We found the percent of  T cells to be significantly greater in late stage lesions 
compared to early lesions in naïve calves (Fig 5A, *p=0.0043) but not in vaccinates.  
When compared to vaccinated calves, the WC1- subset was more heavily recruited to 
early Map infection sites of naïve calves (Fig. 5C, *p<0.05), but the percent of WC1- 
cells decreased over time.  Though the WC1+ subset represented the minority of T 
cells at early infection sites in naïve calves, the percent of WC1+ cells increased 
significantly by the late stages of the infection sites (Fig. 5B, **p<0.05).   
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Discussion  
     Initial cellular interactions at mycobacterial infection sites are considered critical for 
generating effective and sustained protective immunity [40], and an immunoregulatory 
role for  T lymphocytes in this process in humans and cattle has been proposed [41-43].  
Infection site immunopathology is difficult to investigate, and low numbers of T cells 
in most species is an additional challenge to overcome for  T cell studies.  As a result, 
T cell studies have largely been limited to in vitro work using peripheral blood T 
cells (mostly WC1+ in cattle and V2 in humans) and have not examined T cell 
subsets found in lower numbers in peripheral blood (bovine WC1- and human V1).  For 
example, bovine  T cells have been examined within mycobacterial granulomas, but 
these studies examined only WC1+  T cells within granulomas of lymph nodes 
draining infection sites [9, 28, 29].  We thus set out to use an in vivo system to build upon 
the knowledge gained from in vitro (peripheral blood) experiments.  Our study is unique 
because it describes the in vivo recruitment of both WC1+ and WC1-  T cell subsets to 
mycobacterial infection sites in cattle with correlation to the morphology of developing 
granulomas.  Using this model, we have previously described the histology of 
granulomas during generation and maintenance stages at subcutaneous infection sites by 
inducing granulomas on near opposite ends of the morphologic spectrum.  Specifically, 
Map vaccine induced well-organized granulomas resembling tuberculoid type while live 
Map induced unorganized granulomas resembling lepromatous type [37, 38].  Further, we 
have shown a diminished phenotypic and functional maturation status of dendritic cell 
populations harvested from unorganized granulomas compared with those of well 
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organized granulomas [37].  It has been shown that human  T cells are able to enhance 
dendritic cell maturation and thus effect initiation of the adaptive immune response [44-
46], though  T cell-dendritic cell interaction has not been fully investigated in the 
bovine.   
     In the present study, we have identified unique recruitment patterns of  T cell 
subsets that correlate to the degree of granuloma organization and provide evidence to 
suggest that previous antigen exposure influences recruitment of  T cells to an infection 
site.  Lesions that progressed to highly organized granulomas in our study contained 
significantly more WC1+  T cells at initial stages and significantly more WC1-  T 
cells during later stages.  In contrast, lesions without progressive organization during the 
study demonstrated an inverse recruitment pattern of  T cells where WC1- cells 
predominated initially and WC1+ cells were found at elevated numbers at later stages.  
Progressive organization of the granuloma correlated to a distinct stratification pattern of 
 T cell subsets where WC1+ cells localized to marginal (peripheral) regions and WC1- 
cells accumulated adjacent to necrotic (central) regions.  Finally, we observed that WC1- 
 T cells are transiently and preferentially recruited to early mycobacterial infection sites 
in naïve calves but not vaccinated calves.  To our knowledge this has not been previously 
described, but the observation is interesting as one feature of the tissue subset of human 
 T cells (V1 cells compared to V2 cells) is that they also seem to be preferentially 
recruited to local mycobacterial or viral infections [26, 47].   
     These findings suggest that subsets of  T cells play unique roles during the anti-
mycobacterial immune response.  Specifically, WC1-  T cells appear to have an 
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enhanced ability to respond innately to live mycobacteria while WC1+ cells are best 
recruited after antigenic priming and we hypothesize that WC1+ cells function as early 
effector or memory cells during the immune response.  A shift in the predominance of 
WC1+ to WC1- cells over time correlates to the transition from unorganized to a highly 
organized granuloma morphology.  We believe this finding supports the hypothesis that 
 T cell subsets play a role in granuloma organization and/or maintenance during 
pathogenesis of mycobacterial disease, though further studies are needed for 
confirmation. 
     The ability to form organized granulomas to vaccine did not translate to an ability to 
generate highly organized granulomas to subsequent Map challenge.  However, a 
significant difference in morphology of granulomas induced at Map infection sites in 
vaccinates but not naïve calves was the prominence of Langhans-type multinucleated 
giant cells.  Giant cells are observed in a number of neoplastic or chronic inflammatory 
conditions of humans and animals, though few studies have examined inflammatory giant 
cells during mycobacterial infections [48, 49].  A recent in vitro study reported that 
human macrophages responding to virulent mycobacteria (M tuberculosis) formed larger 
multinucleated cells with reduced phagocytic ability and elevated antigen presentation 
capacity compared to macrophages responding to avirulent mycobacteria (M avium).  The 
authors noted that these giant cells resembled mature dendritic cells as a population of 
cells seemingly well-suited for enhanced antigen presentation and hypothesized an 
association with a stronger local host immune response [48].  The presence of Langhans-
type giant cells within Map vaccination sites and live Map infection sites of vaccinated 
but not naïve calves in our study is in vivo evidence to support the hypothesis that 
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Langhans-type giant cells are indicative of the strength and possibly effectiveness of the 
local immune response, though to our knowledge this effect has not been definitively 
shown in vivo during the developing mycobacteria-induced lesions in a species other than 
bovine. 
     We recognize that anatomic and immunologic variables existing between our model 
(skin) and the natural infection site (intestine) may alter the host immune response at 
these locations.  In addition, we know that vaccine adjuvant further influences the local 
immune response, and thus we do not attribute the final consequences of the infection site 
granuloma in our model to any one component of the host immune response described in 
this work.  However, we believe this study demonstrates important features of T cell 
recruitment within unorganized and highly organized granulomas at sites of 
mycobacterial-induced inflammation.  We are now working toward understanding the 
functions of these  subsets and how they influence the induction of either protective or 
non-protective immune responses to mycobacterial diseases.   
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Figure 1 Histology of unorganized and highly organized granulomas.  Panel (A) 
summarizes lesion scores for infection sites (gray bars) and vaccination sites (black bars).  
Late stage vaccine sites scored significantly higher than all other sites (*p<0.0023).  Late 
stage live Map infection sites (B) were unorganized sheets of macrophages and 
lymphocytes without central necrosis or peripheral fibrosis.   Late stage vaccine sites (C) 
were highly organized with macrophages and lymphocytes oriented around central lakes 
of necrotic debris (arrows) with mineral.  Granulomas were encircled by a prominent 
fibrous capsule (arrowheads).  Bar=200m.  
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Figure 2  T cell subsets in poorly organizing and highly organizing granulomas.  
In panel A, the percent of  T cells recruited to unorganized lesions was higher in late 
lesions compared to early lesions (*p=0.0002).  Panels B and C show that in comparison 
to unorganized sites, lesions that became highly organized were dominated initially by 
WC1+  T cells (*p=0.0062) and during later stages by WC1-  T cells (**p=0.0017).   
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Figure 3 Spatial organization of  T cell subsets by immunofluorescent staining. 
Sections from highly organized granulomas were examined for  T cell subset 
organization revealed distinct stratification patterns.  Sections were taken from near the 
fibrous margin (panels B-D) or from near the necrotic center (panels E-G) as indicated by 
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the boxes in panel 3A.  The  TCR is labeled in red (panels B and E), WC1 is labeled in 
green (panels C and F) and nuclei are labeled blue in the overlay images (panels D and 
G).  WC1+  T cells (red and green overlay) are limited to outer margins along the 
fibrous capsule while the lesion centers contain almost predominantly WC1-  T cells 
(single red staining).  Bar = 200m 
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Figure 4 Histology of Map infection sites in naïve and vaccinated calves.  Panel (A) 
shows lesion score summary; late stage lesions scored significantly higher in vaccinates 
compared to naïve calves (*p=0.0449).  Late stage Map infection site lesions in naïve 
calves were characterized by diffuse granulomatous inflammation (see Fig 1B) while 
Map infection sites in previously vaccinated calves (panel B) scored higher due to 
increased fibrous tissue (arrow) and prominent large multinucleated Langhans-type giant 
cells (arrow heads).  Bar=100m  
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Figure 5 T cell subsets in Map infection sites of naïve and vaccinated calves.   The 
percent of  T cells was significantly higher in late lesions compared to early lesions in 
naïve calves (panel A, *p=0.0043) but not vaccinates.  In panels B and C, WC1- 
cells were recruited more heavily to infection sites of naïve calves compared to 
vaccinates (*p<0.05) and the number of WC1+ T cells significantly increased over 
time in infection sites of naïve calves but not in vaccinates (**p<0.05).   
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Abstract 
     We have developed a model to explore the early immune response to Mycobacterium 
avium subspecies paratuberculosis (Map) in the bovine calf using a gel matrix 
biopolymer.  This system utilized subcutaneous placement of a liquid biopolymer 
containing live Map that rapidly polymerizes and retains recruited cellular infiltrates and 
soluble mediators. After 48 hours the matrix is removed and recruited cells and cytokines 
can be measured by histopathology, multi-parameter flow cytometry, enzyme-linked 
immunosorbent assay (ELISA), and Luminex bead-based immunoassays.  A focus of this 
study was to evaluate recruitment patterns of gamma-delta ( and CD4 T cell subsets to 
the mycobacterial infection site, local cytokine generation, and to ultimately determine 
how these cells might influence the development of the adaptive immune response.  Our 
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results show distinct cellular and cytokine profiles in the gels recovered from animals that 
are naïve versus calves previously sensitized to Map antigen.  In addition, our data 
supports our hypothesis that bovine T cell subsets are differentially recruited to early 
mycobacterial infection sites with respect to prior exposure of the host to Map antigens.  
We also found that different bovine T cell subsets display distinct patterns of cytokine 
secretion.  Our results provide unique insight into initial host responses at mycobacterial 
infection sites that may promote novel diagnostic strategies. 
 
Key words: bovine,  T cells, interferon , mycobacteria, paratuberculosis 
 
Introduction 
     The host immunologic response during Map infection in cattle is not completely 
understood.  Transmission of Map occurs most commonly via the fecal-oral route when 
young calves ingest an infectious dose of live Map shed in the feces of infected 
herdmates.  An initial T helper type 1 (Th1) immune response is mediated by IFN 
secreting CD4+ T cells.  A lengthy subclinical period ranging from months to several 
years follows, during which time there is generally absence of clinical signs, histologic or 
gross lesions, bacterial shedding and definitive cellular or humoral evidence of an 
individual‟s infection status [1, 2].  Development of clinical disease is generally 
associated with a loss of CD4+ T cell-mediated immunity, development of T helper type 
2 (Th2) immune response characterized by high levels of Map-specific antibody along 
with development of granulomatous intestinal lesions, clinical signs of wasting, diarrhea 
and eventual death of the host [3].  One of the significant challenges to studying this 
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disease in cattle is effectively modeling the host immunologic responses to Map infection 
within the context of each disease stage over the course of transition from initial Map 
infection to clinical disease.  Specifically, the inability to identify Map-infected animals 
during early stages of disease [4] has significantly impeded examination of the early host 
response to infection.  Review of the current literature reveals these scientific knowledge 
gaps and emphasizes the fact that appropriate models of disease are necessary at all 
stages of Map infection in order to fully elucidate the evolution of this disease [5] and 
potentially enhance the development of future novel diagnostic strategies.  
     Our research group is interested in understanding how the initial immune response to 
Map infection influences development of the subsequent adaptive response and disease 
outcome.  In particular, we are interested in the role that  T cells may play during this 
process.  It is well documented that young calves have large numbers of  T cells in the 
peripheral blood compartment, though specific functions of these cells have not yet been 
clearly defined [6].  Additional details of roles for T cells in many species continue to 
emerge, and though some functions are shared across species, distinctions are also 
apparent.  These cells have been shown to be important effectors or regulators of the 
immune response during mycobacterial or other infections of mucosal sites of mice [7-9], 
humans [10, 11] and cattle [12, 13].  More specifically in cattle,  T cells have been 
demonstrated within mycobacterial-induced lesions [14] and within lymph nodes 
draining mycobacterial infection sites [15-17].   
    Distinct subsets of bovine  T cells have been described [18, 19], and these subsets 
are largely defined by their expression of the unique workshop cluster 1 molecule (WC1) 
as well as CD2 and CD8 expression [20].  Unique roles of both WC1+ [12, 21-25] and 
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WC1- [26, 27] subsets have been reported, but their functional capacity has not been 
completely characterized.  In light of these observations, we have previously utilized the 
subcutaneous model to investigate the host immunopathologic response to Map infection 
[28-30].  Though not a natural route of infection or tissue target, diffuse granulomatous 
lesions induced by subcutaneous Map injection share characteristics of the small 
intestinal lesions observed during early clinical Map infection of cattle.  An advantage of 
this model is that following subcutaneous inoculation, surgically-accessible subcutaneous 
lesions develop rapidly, tend to persist and can thus be monitored over time.  We have 
previously demonstrated differential recruitment patterns of T cell subsets into the 
mycobacterial infection sites of young calves [30], leading us to hypothesize that these 
subsets had distinct functional roles at the infection site.   
     Based on the observations from our previous work, one of the goals of this study was 
to expand the subcutaneous model such that we were able to collect immune cells 
recruited to Map infection sites from live calves for dynamic laboratory analysis, adding 
to our image-based studies within developing granulomas over time.  We adapted a 
technique developed by Russell et al [31], which utilizes Matrigel matrix biopolymer as a 
medium to facilitate collection and extraction of the cells recruited to Map infection sites.  
Utilizing this mechanism, we were able to address a second goal of this study, which was 
to investigate the differential functional capacity of bovine T cell subsets recruited to 
Map infection sites over time.  Results from these experiments are further evidence to 
support the hypothesis that bovine  T cell subsets have distinct roles during anti-
mycobacterial immunity, and they may be key regulators of both local and systemic 
immunologic responses.  Finally, further characterization of these distinct roles may lead 
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to development of translational endeavors including enhancement of novel diagnostic 
testing strategies. 
 
Materials and methods 
     Animals and experimental design.  Twelve (12) five to six week old castrated male 
Holstein calves were acquired from the Iowa State University dairy research farm (Ames, 
IA), a herd certified free of Map infection.  Calves were individually housed in biosafety 
level II animal care facility during the study and were maintained four at a time for 
logistical purposes.  All animal protocols were approved prior to the study by the 
Committee on Animal Care and Use at Iowa State University.  Animals were divided 
randomly into the following groups:  noninfected/naive (n=4), Map infected (n=4) and 
Map vaccinated (n=4).  Animals were administered live Map (1mL in sterile 0.9% 
isotonic saline), Map vaccine (0.5mL Mycopar®, Fort Dodge Animal Health Company, 
Fort Dodge IA) or sham saline (1 mL sterile 0.9% isotonic saline) in the subcutaneous 
space of the left cervical region on post infection day (PID) 0.  In order to evaluate the 
systemic immune response development at Map infection sites, calves were subsequently 
challenged (PID 7, PID 15 and PID 30) with live Map, Map antigen (whole cell sonicate, 
WCS) or saline in BD Matrigel™ in the subcutaneous space (right cervical or paralumbar 
fossa).  These Matrigel challenge sites were harvested approximately 48 hours after 
injection either surgically (PID 7 and PID 15) or during necropsy (PID 30).     
     Vaccine.  M. avium subspecies paratuberculosis bacterin (Mycopar®, Fort Dodge 
Animal Health Company , Fort Dodge IA) was used in this experiment.  Mycopar® is a 
whole-cell bacterin containing inactivated Mycobacterium paratuberculosis in oil. 
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     Generation of Map antigen (whole cell sonicate, WCS).  Late growth phase live 
Map K10 bacteria suspended in approximately 250 mL Middlebrook 7H9 broth 
supplemented with mycobactin J were collected from culture stock in our laboratory.  
Bacteria were pelleted by centrifugation at 3500 G for 20 minutes, washed twice with 
cold phosphate buffered saline (PBS) and pooled into approximately 10 mL cold PBS 
and sonicated on ice with a probe sonicator.  Sonication consisted of three cycles of 10 
minute bursts (18 watts) with 10 minute chilling periods between sonication steps.  
Debris is removed by centrifugation at 12000 G for 5 minutes and supernatants were then 
harvested and stored at -20°C.  Protein concentration was determined using the Pierce 
BCA protein assay (Pierce Biotechnology, Rockford, IL).  Approximately 250L whole 
cell sonicate (WCS) was streaked onto blood agar and incubated for 24 hours at 37°C to 
check for contamination prior to use.   
     Bacterial inoculum, infection and challenge.  The Map strain K10 was obtained 
from the National Animal Disease Center (Ames, IA) and maintained in Middlebrook 
7H9 broth supplemented with mycobactin J.  Logarithmic growth-phase bacteria were 
washed and resuspended in sterile saline for inoculation or challenge.  The Map inoculum 
used in these studies was shown to have greater than 90% viability via fluorescein 
diacetate (FDA) staining and flow cytometry analysis prior to inoculation.  In addition, 
challenge inocula were confirmed negative for contaminants by streaking onto sheep 
blood agar plates 24 hours prior to injection.  Bacterial concentration was determined by 
measuring absorbance at 540 nm, comparing the absorbance optical density to the 
standard curve, and adjusted to appropriate final concentration.  For initial infection, 
bacteria were diluted to a final concentration of 1 X 10
9 
CFU/mL in 0.9% isotonic saline 
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solution.  For challenge, bacteria were diluted to a final concentration of 1 X 10
6
 
CFU/mL in 0.9% isotonic sterile saline.   
     Matrigel™.  BD Matrigel Basement Membrane Matrix (Matrigel™, BD Biosciences, 
Bedford, MA) is a commercially available purified solubilized basement membrane 
preparation extracted from the Engelbreth-Holm-Swarm mouse sarcoma.  Matrigel™ 
(hereafter referred to as Matrigel) was stored at -20°C and thawed at 4°C by placing on 
ice 24 hours prior to use.  Immediately prior to challenge, live Map (1 X 10
5
 CFU), Map 
antigen (WCS, 5g) or an equal volume of sterile saline was added to 500L aliquots of 
thawed Matrigel.   
     Collection and processing challenge sites for flow cytometry or culture.  At PID 7 
and PID 15, animals were heavily sedated (0.1 mg/kg xylazine IM followed by 2.0mg/kg 
ketamine IV), placed in lateral recumbency and the surgical sites were sterilely prepared 
for surgical removal of Matrigel plug sites.  At PID 30, calves were euthanized with an 
intravascular overdose of pentobarbital sodium (Beuthanasia-D®, Intervet/Schering 
Plough Animal Health Company).  A single cutaneous incision was placed overlying the 
challenge site and the Matrigel material was visually identified in the subcutaneous 
space, removed and placed into 5mL sterile isotonic saline and transported on ice to the 
laboratory for evaluation.  In live animals, skin incisions were then sutured closed and the 
calves were allowed to recover.  Cells harvested directly from the Matrigel Map 
inoculation sites were transported on ice to the laboratory for flow cytometry and/or 
culture.  Total cell number was determined using a Beckman Coulter counter (Beckman 
Coulter Inc, Miami, FL).  Cells were then resuspended in either sterile PBS (for cell 
surface marker staining and flow cytometry) or complete RPMI (for cell culture) at a 
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final concentration of 1x10
6
 cells per 100L media.  PBMC were collected by jugular 
venipuncture, the buffy coat was separated from the whole blood, remaining erythrocytes 
were lysed and PBMC were washed twice with PBS.  Gamma-delta () T cell subsets 
were sorted from PBMC using autoMACS beads technology on autoMACS cell 
separation column per the manufacturer‟s instructions (MiltenyiBiotec Inc, Auburn, CA).  
Briefly, workshop cluster 1 (WC1) expressing T cells were positively selected from 
PBMC using mouse anti-bovine WC1(n1) IgM primary antibody (B7A1, VMRD Inc, 
Pullman, WA, USA) at a dilution of 1:50 followed by rat anti-mouse IgM microbeads at 
dilution 1:5 (MiltenyiBiotec).  Following the initial sort,  T cells were positively 
selected from the previously sorted WC1- subpopulation using mouse anti-bovine delta 
chain T cell receptor (GB21A, VMRD) at a dilution of 1:50 followed by rat anti-
mouse IgG2a+b microbeads (MiltenyiBiotec) at dilution of 1:5.  Following the second 
sort using autoMACS cell separation column, two distinct populations of  T cells were 
achieved:   TCR+/WC1 and  TCR+/WC1+.  Prior to culture, the purity of these 
populations was verified using two color flow cytometry to be greater than 85% (data not 
shown).   
     Monoclonal antibodies and antigens.  The following mouse anti-bovine monoclonal 
antibodies were used to characterize T cell phenotype by multi-color flow cytometry:  
anti- TCR (GB21A, VMRD, Pullman WA, USA), anti-WC1(n1) (B7A1, VMRD), anti-
CD4 (CACT138A, VMRD) and anti-IFN (MCA1964, Serotec, Raleigh NC).  Secondary 
antibodies (all from Invitrogen Molecular Probes, Carlsbad CA) included Alexa-fluor 
488-conjugated goat anti-mouse IgG2b ( TCR), phycoerythrin (PE)-conjugated goat 
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anti-mouse IgM (WC1), PE-conjugated goat anti-mouse IgG1 (CD4), and Alexa-fluor 
700-conjugated goat anti-mouse IgG1 (IFN).  For intracellular cytokine staining, surface 
markers were stained as described above and cells were fixed in 2% paraformaldehyde 
for 20 minutes.  The cells were then permeabilized using permawash buffer (0.1% 
saponin, 0.1% sodium azide in 1X phosphate buffered saline) followed by addition of 
primary and secondary antibodies.  Cells were stored in 2% paraformaldehyde solution 
prior to flow cytometry. 
     Flow cytometric data collection and analysis.  Flow cytometric data were collected 
using a FACSCanto flow cytometer (Becton Dickinson Biosciences, San Jose, CA), and 
FlowJo cell analysis software (Tree Star Inc, San Carlos, CA) was used to analyze data.   
     Cell culture.  Total recruited Matrigel site cells or purified  T cell subsets were 
suspended in complete RPMI 1640 complete medium (diluted or concentrated to a final 
concentration of 1x10
6
 cells/well) in 96-well plates.  Where appropriate, antigen was 
added prior to culture for 6 days at 37° C.  Whole cell sonicate was used at a final in-well 
concentration of 5g/mL, and recombinant human interleukin-2 (rhIL2, Peprotech Inc, 
Rocky Hill NJ) to a final concentration of 1ng/mL. 
     Luminex® Immunoassay.  Gel or culture supernatants were incubated with agitation 
for 2 hours at room temperature, then overnight at 2-8°C with mouse anti-bovine IFN-
coupled Luminex® beads.  After addition of detection antibodies (biotin-labeled mouse 
anti-bovine IFN; streptavidin-PE), mean fluorescence intensities of individual samples 
(in duplicate) were compared to standard curve to determine cytokine concentrations.  
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     Whole blood IFN assay.  IFN ELISA assay was performed according to the 
manufacturer‟s instruction (Mycobacterium bovis gamma interferon test kit for cattle, 
Bovigam®, Prionics USA, Inc, LaVista, NE).  Briefly, whole blood was collected into 
heparinized tubes, and aliquoted to 1mL/well in 6 well plates.  In place of the kit-supplied 
M bovis antigen, Map K10 strain WCS antigen (10g/well) was added to appropriate 
wells and samples were incubated at 37°C.  After 24 hours, the supernatant was harvested 
from each well and stored at -80°C until analysis.  Optical density (OD) ratios were 
derived by dividing the OD (450nm) of the sample by the OD (450nm) of the positive 
control, provided in the kit by the manufacturer. 
     Delayed-type hypersensitivity reaction.  DTH was assessed by measuring the skin 
pinch thickness 72 (+/- 6) hours following intradermal injection of 0.1mL of purified 
protein derivative (Johnin PPD=4.6mg/mL, National Veterinary Services Laboratories, 
Ames IA).   
     Statistical analysis.  Statistical analysis was performed using JMP 8.0.2 (SAS 
Institute, Cary, NC).  Data are presented as the mean values ± standard error of the mean.  
Student‟s t-test and one-way analysis of variance (ANOVA) were used for the statistical 
analysis, unless otherwise specifically stated.  Group mean differences were considered 
significant if the p value was <0.05, and highly significant if the p value was <0.01.   
 
Results 
     Model description.  Following initial Map infection or vaccination, we evaluated the 
systemic and localized host immune responses to Map at three time points (early, middle, 
late).  Systemic immune responses were measured using two methods: 1) the peripheral 
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blood leukocyte-generated Map-specific interferon gamma (IFN) assay, and 2) the Map 
purified protein derivative (PPD)-induced delayed-type hypersensitivity reaction (DTH).  
The local host immune response was measured at Matrigel only or Matrigel with Map 
infection sites in calves at three time points (early, middle and late).  Also, at each 
Matrigel only or Matrigel with Map infection site, we evaluated gross and histologic 
changes, measured quantity and phenotype of recruited cells and quantified secreted 
cytokines at each time point.   
     Systemic immune response.  First we measured Map-specific IFN production by 
peripheral blood leukocytes at each time point and the data are shown in figure 1a.  As 
expected, minimal IFN was generated initially and differences were not observed 
between groups prior to Map challenge or vaccination.  Compared to pre-challenge, only 
vaccinates generated significantly more Map-specific IFN at the late (PID 30) time point 
(Fig. 1a, *p=0.0103).  In addition to Map-specific IFN, we also measured systemic 
immune response at PID 30 by delayed type hypersensitivity (DTH) reaction using the 
skin test, which is commonly utilized for evaluation of the cell-mediated response to 
mycobacterial infections in humans and animals.  The data are shown in figure 1b, and 
using the cross-sectional skin thickness measured at PID 30 we were able to distinguish 
calves based on their treatment group (Fig. 1b, p<0.01 for each group).   
     Local (infection site) immune response.  Grossly subtle but digitally palpable soft 
tissue swelling was detected at Matrigel Map infection sites in Map-sensitized animals 
(Map infected or Map vaccinated) but not naïve calves at all time points.  A significant 
benefit of Matrigel is that the inoculation site can be evaluated histologically and 
infiltrating cells are easily recovered after surgical removal of the Matrigel plug.  In 
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figure 2, representative photographs of the gross and histologic appearance of a Matrigel 
only site (Fig. 2a, b) and Matrigel Map infection site (Fig. 2c, d) is shown.  At Matrigel 
only sites (Fig. 2a, b) very few leukocytes were recruited while at Matrigel Map infection 
sites, large numbers of leukocytes were recruited and these cells were intermixed with 
fibrin (Fig. 2d).  For each time point, we used a Beckman-Coulter cell counter to quantify 
total cells recruited to each site in naïve and Map sensitized calves, and this data is 
summarized in figure 3.  More cells were recruited to Matrigel sites at the late time point 
(PID 30) compared to the early time (PID 7) point in all calves (Fig. 3a, *p<0.0001).  At 
the early time point, more cells were recruited to Matrigel sites in Map sensitized calves 
compared to naïve calves (Fig. 3b, #p=0.0507).  At the late time point, no difference was 
observed between total cells recruited to Matrigel sites of Map sensitized or naïve calves 
(data not shown). 
     Phenotype of cells recruited to Matrigel Map infection sites.  In order to evaluate 
the dynamic T cell response at Map infection sites in this model, we used flow cytometry 
to compare the phenotypic recruitment patterns of T cells recruited to Matrigel with Map 
sites at each time point.  For this study, we focused specifically on CD4 and T cells, 
and the data are shown in figure 4.  T cells were significantly recruited to early 
Matrigel Map sites of all calves (naïve, infected and vaccinated) compared to late 
Matrigel Map sites, though it was statistically significant only in naïve calves and 
vaccinates (Fig. 4a, p<0.0033).  In contrast to the recruitment dynamics of  T cells, 
significant numbers of CD4+ T cells were recruited only to late Matrigel Map infection 
sites in vaccinated calves but not Map infected or naïve calves (Fig. 4b, p=0.0427).    
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     IFN production at Matrigel Map infection sites.  As an additional measure of the 
local immune response, we measured IFNprotein secretion into Matrigel alone or 
Matrigel Map infection sites in all calves.  Compared to late time points (Fig. 5b), we 
detected low amounts of secreted IFNwithin Matrigel only or Matrigel Map infection 
sites at early time points (Fig. 5a, notice y axis scale difference between panels a, b).  
Compared to Matrigel only sites, higher IFNwas detected in Matrigel Map infection 
sites in Map infected calves at the early time point (Fig. 5a, p=0.0339, 
Wilcoxon/Kruskal-Wallis test), and in Map vaccinated calves at the late time point (Fig. 
5b, p<0.0339).   
     IFN production by T cell subsets.  Based on  T cell infiltration and IFN 
secretion profiles, we used two experimental techniques to investigate the hypothesis that 
bovine  T cells recruited to early Map infection sites are capable of secreting 
significant amounts of IFN.  First, we collected total recruited leukocytes from Matrigel 
Map infection sites for culture.  After 6 days culture with WCS-stimulation, we used flow 
cytometry to label both the surface T cell receptor (TCR) and intracellular IFN.  
The results of this flow cytometric study are depicted graphically in figure 6.  The percent 
of TCR expressing cells (as a percent of total live cells) following culture (Fig. 6a) was 
similar to the percentage of TCR expressing cells prior to culture and harvested directly 
from Matrigel Map infection sites (shown in Fig. 4a) at all time points.  The percentage 
of TCR expressing cells correlated well with the percentage of TCR expressing cells 
that also expressed IFN (Fig. 6b, TCR+IFN+).  Following culture and WCS-
stimulation, there is a significantly higher percentage of TCR+IFN+ cells from 
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Matrigel Map infection sites at early time points compared to later time points (Fig. 6b, 
*p=0.0087).   Even though most TCR+ cells after culture produced IFN, we found 
that the majority of IFN produced by cells recruited to both Matrigel alone and Matrigel 
Map infection sites after culture was by non-TCR expressing cells (Fig. 6c, TCR-
IFN+ cells).  Further phenotypic information about this particular cell population was 
not specifically investigated in this study; however likely candidates include T cells, 
natural killer (NK) cells or NK T cells.   
     Because cattle have large numbers of  T cells in peripheral blood, we also collected 
peripheral blood T cells from our calves and sorted these into subpopulations based on 
their expression of the surface marker workshop cluster 1 (WC1).  We thus obtained two 
distinct populations of peripheral blood  T cells defined by their surface phenotype:  
WC1+TCR+ and WC1-TCR+.  At each time point, we cultured peripheral blood-
derived  T cell subsets to measure their ability to secrete IFN as a response to 
secondary stimulation with media alone, media with rhIL2, or Map antigen (WCS) and 
rhIL2.  Without the addition of rhIL2 to cell cultures in our system, we were unable to 
detect responses in purified populations of T cells (data not shown).  Regardless of 
time (PID 0 vs. PID 30) or prior Map antigen sensitization status (naïve vs. sensitized), 
the WC1-TCR+ enriched cell populations demonstrated the greatest capacity for IFN 
generation (Fig. 7a, b).  In particular, we found that the WC1-TCR+ enriched cell 
population from naïve calves generated significantly greater amount of IFNcompared to 
WC1+TCR+ enriched cell population from the same calves (Fig. 7a, *p=0.0153).  Only 
after antigen sensitization of the animals were the WC1+TCR+ enriched cell 
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population of cells able to produce IFN (Fig. 7b).  We found that the ability to generate 
IFN by both subsets of peripheral blood-derived  T cells was rhIL2 dependent.  It is 
clear that WC1-TCR+ cells are able to generate IFN in a Map antigen independent 
manner; however the role for Map antigen during stimulation of IFN production by 
WC1+TCR+ cells is less clear.   
 
Discussion 
     Much effort has been focused on study of the bovine immune response during 
subclinical or clinical Map infection by evaluation of lymph node cells, intestinal 
mucosal (lamina propria) cells or peripheral blood cells [32-34], yet the ability to 
investigate immunologic responses at the initial Map infection site has thus far been 
elusive [35, 36].  This distinct gap in understanding the early immune response to Map 
infection in cattle emphasizes the need for models by which factors that shape the early 
response to Map and development of Map-associated disease can be clarified.  The goal 
of the current study was to further evaluate the early host response to subcutaneous Map 
infection in calves to facilitate identification of novel features of the response that may be 
useful for development of new diagnostic strategies.      
     A limitation to the subcutaneous granuloma model is the difficulty of efficient 
collection of recruited cells for ex vivo analysis without excessive manipulation of the 
tissue which may induce alterations of cellular phenotype or function.  Adaptation of this 
model by inclusion of Matrigel greatly facilitated collection of recruited cells for ex vivo 
laboratory analysis; however because Matrigel is a product of murine sarcoma, we 
observed the development of significant immunologic responses to the Matrigel vehicle 
95 
 
in Map-naïve calves upon repeated Matrigel exposure.  We observed the recruitment of 
minimal inflammatory cells in response to Matrigel without antigen (Fig. 2a, b).  At the 
early time point, more total leukocytes were recruited to Matrigel sites in Map antigen 
sensitized calves compared to naïve calves (Fig. 3b); however at subsequent Matrigel 
injections we observed the recruitment of significant inflammatory cellular infiltrates in 
all animals (Fig. 3a).  This impeded interpretation of the immunologic data at late time 
points because were unable to differentiate Map-specific from Matrigel-specific 
immunologic responses in some calves (most prominent in total recruited cell number).  
Thus, total recruited cells to Matrigel Map sites may be useful for determining Map 
exposure in naïve calves.  Regardless, we were able to demonstrate the development of 
distinct systemic immunologic responses in Map-infected and Map-vaccinated calves in 
this study using the DTH and IFN tests (Fig. 1).   
     Consistent with the current immunologic pattern of mycobacterial diseases, Map 
sensitization in our experimental system resulted in the development of an IFN-secreting 
memory CD4+T cell-mediated response.  This was detected in our system by whole 
blood leukocyte IFN assay, DTH responses (Fig. 1), as well as by recruitment of 
increased CD4+T cells to Matrigel Map sites at late time points (Fig. 4b) in this system.  
Interestingly, recruitment of  T cells has an opposing pattern to that of CD4+ T cells in 
our study.  Previous work in our laboratory in which immuno-fluorescence microscopy 
was utilized to investigate the involvement of bovine  T cell subsets in Map-induced 
granulomatous lesions over time suggested differential roles for  T cell subsets at Map 
infection sites [30].  Based on this work, our hypothesis for the current study was that the 
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WC1-TCR+ subset was recruited heavily to initial Map infection sites of naïve calves 
where they were able to influence the development of the subsequent immune response 
specifically via IFN secretion.  In the prior study, we also showed that WC1+T cells 
were recruited more heavily to Map infection sites following antigenic priming and this 
shaped our new hypothesis for the current study that these cells function primarily as 
early effector or memory cells during the anti-mycobacterial immune response in calves.   
     For the present study we were limited to two simultaneous labels per flow cytometric 
assay and future work needs to be done to confirm the recruitment patterns of specific  
T cell subsets (WC1+ vs. WC1-).  We were able to show that peripheral blood derived 
T cell subsets of cattle display a striking differential ability to generate IFNduring 
the course of infection.  This evidence suggests that, at least for the WC1- subset, ability 
to generate IFN is not dependent on antigen as WC1-TCR+ cells from naïve and 
antigen-sensitized calves consistently generated large amounts of IFN in an IL2-
dependent but antigen-independent manner.  Our data also suggests that WC1+TCR+ 
cells have moderate ability to generate IFN, but this was observed only when the cells 
originated from calves previously sensitized to Map antigen (already primed) and not 
from naïve calves.   
     The activation of bovine  T cells has been recently described in two distinct stages.  
It has been known for some time that  T cells are non-major histocompatibility (MHC) 
restricted, and capable of responding to pathogen-associated molecular patterns 
(PAMPs).  The subtle responses by  T cells to PAMPs has been termed antigenic-
independent priming, and primed cells are in fact defined by upregulation of interleukin 
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2-receptor  (IL2R [37, 38].  Primed T cells have been shown to robustly produce 
cytokines in response to secondary signals such as IL2 or specific antigen [37, 39].  It 
was recently demonstrated that naive lymphatic-derived but not T cells from calves 
with enteric salmonellosis were primed early during infection as shown by upregulation 
of both the IL2-R gene and IL2-R protein on the cell surface.  In that study evidence 
of  T cell proliferation or pro-inflammatory cytokine secretion was not reported, but the 
authors concluded that both events were likely to occur secondary to downstream 
signaling effects [40].  In our study, these distinct stages (priming vs. secondary 
activation) were not clearly defined; however our data offers further support to the 
hypothesis that T cell subsets are capable of significant IFNgeneration at Map 
infection sites.  In the previous models, other investigators have hypothesized that the 
localized response by T cells may be sufficient to control infection and that primed  
T cells would then return to a resting state [37].    
     Further work in our laboratory will be directed toward more clearly understanding the 
role of T cells in our system.  Reports in humans and mice have shown that T cell 
subsets are capable of modulating the adaptive immune response [41-47].  We are also 
interested in understanding how bovine  T cell subsets initially recruited to Map 
infection sites may function locally in control or progression of disease, and how these 
cells may influence the eventual development of the adaptive immune response to Map in 
cattle.     
     We recognize that the subsets of  T cells in humans and animals continue to be 
characterized and their functions clarified, and a definitive functional link between T 
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cells of peripheral blood and those of various mucosal sites has been elusive.  However, 
we believe that the subcutaneous model is useful for defining initial features of the host 
response and this should prove beneficial for improvement of current diagnostic tests or 
development of novel diagnostic strategies during early Map infection in cattle. 
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Figure 1 Systemic immune responses in naïve, infected, and vaccinated calves.  
Compared to pre-challenge times (PID 0), significantly greater amount of Map-specific 
IFN was generated by whole blood in vaccinates but not Map infected or naïve calves at 
the late time point (Fig. 1a, PID 30, *p=0.0103).  Delayed type hypersensitivity reaction 
was able to distinguish all groups (naïve, Map infected, Map vaccinated) at PID 30 (Fig. 
1b, p<0.01 between all groups).   
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Figure 2 Subcutaneous space from Map antigen sensitized calves showing gross (Fig. 2a, 
c) and histologic (Fig. 2b, d, HE stain) appearance of Matrigel injection sites.  In Matrigel 
only sites (Fig. 2a, b), few leukocytes were recruited after 48 hours, though erythrocytes 
were present (Fig. 2b, arrows).  When 10
5
 live Map were added to the Matrigel (Fig. 2c, 
d), large numbers of leukocytes were intermixed with fibrin at the injection site.   
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Figure 3 Total recruited leukocytes to Matrigel sites in all calves.  Significantly more 
cells were recruited to Matrigel sites at the late time point compared to the early time 
point (Fig. 3a, *p<0.0001).  At the early time point, more cells were recruited to Matrigel 
sites in Map sensitized calves compared to naïve calves (Fig. 3b, #p=0.0507).   
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Figure 4 Recruitment of  T cells and CD4+ T cells to Matrigel Map infection sites in 
naïve, infected and vaccinated calves over time.  Compared to CD4+ T cells, T cells 
were recruited to Matrigel Map infection sites in naïve and vaccinated calves at early 
time points (Fig. 4a, p<0.0033).  CD4+ T cells were recruited to Matrigel Map infection 
sites only in vaccinated calves at late time points (Fig. 4b, p=0.0427).  Letters indicate 
statistically significant differences between groups.  
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Figure 5 Secreted IFN within Matrigel alone or Matrigel Map infection sites in naïve, 
infected and vaccinated calves.  At early time points (panel a), Matrigel Map infection 
sites contained greater amounts of secreted IFN compared to Matrigel only sites; 
however this was statistically significant only in Map infected calves (Fig. 5a, p=0.0339, 
Wilcoxon/Kruskal-Wallis test).  At late time points (panel b), significantly greater levels 
of IFN were secreted at Matrigel Map infection sites in vaccinated calves compared to 
the other groups (Fig. 5b, p=0.0339).  At early time points, significantly less IFN protein 
was detectable compared to late time points; note the scale difference between panel a 
and panel b. 
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Figure 6 IFN is produced by cells recruited to early Matrigel sites compared to later 
time points, regardless of previous antigen sensitization status of the animal, dual color 
flow cytometry data.  After culture, significantly higher percentage of cells expresses 
TCR in early (22.7%) Matrigel Map infection sites compared to late (3.9%) Matrigel 
Map infection sites (Fig. 6a, *p=0.005).  More  T cells from early (13%) Matrigel Map 
infection sites produce IFN compared to the late (1.3%) time point (Fig. 6b, *p=0.0087).  
After culture, the majority of IFNis produced by non-T cells from early Matrigel 
alone sites (Fig. 6c, 38.5%, *p=0.0026) and Matrigel Map infection sites (Fig. 6c, 8.7%, 
**p=0.0119) compared to late time points (Fig. 6c, 8.7%, 9.4%, respectively).   
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Figure 7 Differential IFN production by IL2-stimulated bovine peripheral blood derived 
T cell subsets.  Non-stimulated (media) cells of both T cell subsets at all times 
generated minimal IFN.  In naïve calves (Fig. 7a, PID 0), cultured enriched WC1-
TCR+ cells secreted significantly higher amounts of IFNafter stimulation with 
recombinant human interleukin 2 (rhIL2) compared to culture enriched WC1+TCR+ 
cells from the same calves (Fig. 7a, *p=0.0153).  In sensitized calves (Fig. 7b, PID 30), 
cultured enriched WC1-TCR+ cells stimulated with rhIL2 secrete higher amounts of 
IFN compared to cells stimulated with media alone (Fig. 7b, *p=0.0084). 
  
111 
 
CHAPTER 4:  DIRECT INOCULATION OF MYCOBACTERIUM AVIUM 
SUBSPECIES PARATUBERCULOSIS INTO ILEOCECAL PEYER’S  
PATCHES RESULTS IN COLONIZATION OF THE  
INTESTINE IN A CALF MODEL 
 
A paper published in the journal Veterinary Pathology 
Vet Pathol; 7 Oct 2010 (epub) DOI: 10.1177/0300985810383874 
 
Brandon L. Plattner
1
, Yu-Wei Chiang
3
, James A. Roth
2
,
 
Ratree Platt
2
,  
Elise Huffman
1
, Jean Zylstra
3
, and Jesse M. Hostetter
1
 
 
Departments of Veterinary Pathology
1
 and Veterinary Microbiology and Preventive  
Medicine
2
, College of Veterinary Medicine, Iowa State University, Ames, IA, USA  
and Fort Dodge Animal Health
3
, Fort Dodge, IA, USA 
 
Abstract 
     The objective of this study was to develop an intestinal model of Mycobacterium 
avium subspecies paratuberculosis (Map) infection in the calf for evaluation of mucosal 
pathology, and local and systemic immunologic responses.  We inoculated Map into 
Peyer‟s patches of young calves using a right flank surgical approach in standing calves 
to exteriorize the ileocecal junction.  Inoculum dosages ranging from 10
3
 to 10
9
 colony 
forming units of strain K10 Map were injected through the serosal surface into Peyer‟s 
patches of the distal ileum near the ileocecal valve.  Fecal samples were collected for 
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culture from each calf weekly until termination of the study.  Calves were necropsied at 
07, 30, 60, and 90 days post infection when inoculation sites, lymph nodes, spleen, and 
peripheral blood were collected for evaluation.  Ileocecal lymph nodes (ICLN) were 
consistently colonized by Map in the 10
5
-10
9
 groups.  The ileocecal valve was also 
colonized in 10
7
 and 10
9
 group animals.  This correlated with fecal culture results as 
infected calves intermittently shed Map in their feces throughout the study.  We identified 
granulomatous lesions with giant cells and acid-fast bacilli at the ileocecal junction, 
ileocecal lymph nodes, and lamina propria of high dose animals (10
7
 and 10
9
) from each 
time point.  Flow cytometry was used to detect antigen-specific production of IFN and 
IL-4 locally (ICLN) and systemically (PBMC) which defined distinct immunologic 
profiles in low dose and high dose calves.  This study demonstrates intestinal Map 
infection via Peyer‟s patch inoculation, a novel model with many shared features of 
natural Map infection.    
 
Key words:  bovine, immunology, intestinal, mycobacteria, paratuberculosis 
 
Introduction 
     Mycobacterium avium subspecies paratuberculosis (Map) is the causative agent of 
ruminant paratuberculosis (Johne‟s disease), a disease widely distributed in domestic and 
free-range ruminants throughout the world.  The prevalence is unknown in many parts of 
the world, but in the United States it has been recently estimated to affect as high as 68% 
of dairy herds [1].  Economic losses result directly from reduced milk yield, premature 
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culling, and reduced slaughter value, and indirectly as shedding adults serve as a source 
of infection for susceptible herd mates and young calves [2].   
     A considerable amount of research using a variety of experimental model systems has 
been devoted to this disease in recent years, yet the pathogenesis of intestinal Map 
infection remains incompletely understood.  It is generally accepted that infection occurs 
primarily during the neonatal period when calves ingest an infectious dose of Map 
primarily from feces or colostrum.  The organism is likely endocytosed by epithelial M 
cells overlying ileal Peyer‟s patches, and subsequently phagocytosed by subepithelial 
macrophages and dendritic cells [3].  A major challenge for studying the disease is the 
lengthy subclinical infection period of Map (from 2 to 5 years) and the difficulty 
associated with accurate identification of infected animals during this period.  A number 
of recent studies in cattle have documented infection by tissue culture, fecal culture, 
and/or polymerase-chain reaction following oral inoculation [4-12] or intra-tonsillar 
inoculation [11]; however intestinal histopathologic lesions containing acid-fast bacteria 
are not a consistent feature of experimental infection.   
     In a recent review of experimental model systems for studying Map infection, Hines et 
al. [13] articulated pressing knowledge gaps regarding Map infection which include the 
following questions.  How does early tissue colonization relate to protection or lack of 
protection?  Is there correlation between tissue colonization and fecal shedding?  What is 
the optimal-but-practical number of necropsy tissues to collect for culture and 
histopathology?   
     Given the lengthy time course and cost associated with studying natural disease and in 
view of recent recommendations for studying Map infection, our objective for the current 
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study was to develop a short-term experimental calf model in order to adequately address 
these unanswered questions relevant to the immunopathogenesis of intestinal Map 
infection.  With the rationale that submucosal Peyer‟s patches of the distal ileum are the 
initial site of Map infection in the calf, our hypothesis was that direct delivery of an 
infectious dose of live Map into this anatomic location is sufficient to induce rapid 
intestinal infection with pathologic and immunologic similarity to naturally occurring 
disease.  We set out to establish intestinal Map infection by injecting bacteria directly 
into the proposed site of natural infection in young calves, and we thus designed the 
experiment to test a range of appropriate inoculation dosages. Our overall study goals 
were two-fold.  First, we utilized bacteriology and histopathology to determine the 
optimal Map dosage that results in intestinal colonization after direct inoculation.  
Second, we evaluated key T-helper cytokine expression patterns (interferon  and 
interleukin-4) both locally and systemically to characterize the progression of local and 
systemic immune responses in infected calves.    
 
Materials and methods 
     Experimental design and animals.  The experimental design is outlined in table 1.  
Briefly, forty (40) five week old castrated male dairy breed calves (Holstein, Jersey, and 
Brown Swiss) were acquired for the study from various local private dairy herds.  All 
herds were actively participating in the voluntary Johne‟s disease certification program, 
and have not had positive cases for at least 2 years.  Animals were housed within the 
biosafety level 2 large animal housing facilities on the campus of Fort Dodge Animal 
Health in Fort Dodge, IA for the duration of this study.  Calves were housed in groups of 
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7-9 animals based on randomly assigned Map dosage.  Control calves were housed 
separate from infected calves and their feces.  Live Map was prepared in colony forming 
units (cfu) per dose including: 10
3
 (n=7), 10
5
 (n=7), 10
7
 (n=9), 10
9
 (n=9), and uninfected 
negative control (n=8).  Each group was separately housed, but for logistical purposes the 
two low dose groups (10
3
 and 10
5 
cfu) were infected simultaneously and the two high 
dose groups (10
7
 and 10
9
 cfu) were infected simultaneously.  For each group, individual 
calves were randomly selected for euthanasia at the following time points (post infection 
day, PID):  PID 07 (n=1-2), PID 30 (n=2), PID 60 (n=2), and PID 90 (n=2-3).  A single 
uninfected control animal was sacrificed at each time point for low dose and high dose 
groups.  All live animal protocols were approved prior to the experiment by the internal 
Institutional Committee on Animal Care and Use (IACUC) at the Fort Dodge Animal 
Health Company.   
     Bacterial inoculum preparation.  The Map strain K10 was obtained from the 
American Type Culture Collection (Manassas, VA), and maintained in Middlebrook 7H9 
broth supplemented with mycobactin J.  Logarithmic growth-phase bacteria were washed 
and suspended in sterile saline.  Bacterial concentration was determined by measuring 
absorbance at 540 nm and comparing the optical density to a standard curve generated in 
our laboratory.  By dilution or concentration, inocula were adjusted to the appropriate 
final concentration of 10
3
-10
9 
cfu/250 L in 0.9% sterile saline solution.  The inoculum 
used in these studies was shown to have greater than 90% viability using fluorescein 
diacetate (FDA) staining with analysis by flow cytometry prior to inoculation.  Challenge 
inocula were confirmed to be acid fast by Ziehl-Nielson (ZN) staining and negative for 
contaminants by streaking onto sheep blood agar plates 24 hours prior to injection. 
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     Animal inoculation.  Animals were inoculated via direct subserosal injection into the 
Peyer‟s patch regions in the distal ileum adjacent to the ileocecal valve.  Briefly, a right-
sided approach to the ileocecal valve was utilized through a 4-5cm vertical incision in the 
paralumbar fossa using local anesthesia in standing calves.  Once access to the 
peritoneum was achieved, the cecum and distal ileum were isolated and exteriorized.  The 
anti-mesenteric Peyer‟s patches of the distal ileum were visualized and 250 L 
containing the appropriate dosage of live Map K10 was injected.  The intestine was then 
replaced into the abdominal cavity and the body wall was sutured using a standard three-
layer closure.  Sterile instrumentation and surgical techniques were used, and peri-
operative systemic antibiotics were not administered. 
     Bacterial fecal and tissue cultures.  Following inoculation, fecal samples were 
collected per rectum from each calf (PID 01-02), and then weekly for the duration of the 
study.  Fecal samples and tissue samples collected at necropsy were cultured using the 
BACTEC MGIT 960 system (BD Biosciences, Sparks, MD, USA).  All samples positive 
by the BACTEC culture system were subsequently subjected to PCR for confirmation by 
identification of the unique Map sequence IS900.  Within the text of this manuscript, 
culture positive status is only used to indicate fecal or tissue samples that were positive 
by both the BACTEC culture system and confirmatory PCR testing.   
     Polymerase chain reaction.  Tissue and fecal samples identified as positive using 
BACTEC liquid culture system were verified as Map using real time polymerase chain 
reaction (PCR) to detect the Map-specific sequence IS900.  Genomic DNA was extracted 
from egg yolk media-grown bacterial cultures using a beadbeater (4500rpm for 5 
minutes), high-speed centrifugation (16000g for 10 minutes) followed by alcohol 
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precipitation of the bacterial nucleic acid.  Commercially available oligonucleotide 
primers were derived from the IS900 DNA insertion sequence unique to Map (forward 
5‟-CCGCTAAATGAGAGATGGGATTGG-3‟ and reverse 3‟-
ATTCAACTCCAGCAGCGCGGCCTCG-3‟, Integrated DNA Technologies, Coralville, 
IA).  A commercially available IS900 fluorescent probe (IDT, Coralville, IA) was used 
for detection.  
     Tissue and sample collection.  At each time point small groups of 5-6 calves were 
humanely euthanized, and the following tissue samples were collected during a complete 
necropsy examination:  ileocecal valve (ICV), ileocecal lymph node (ICLN), mesenteric 
lymph node, pre-scapular lymph node, liver, spleen, and ileum.  All tissues were 
aseptically collected and placed either into sterile containers for mycobacterial culture or 
into 10% neutral buffered formalin for histopathologic evaluation.  An additional 4-5 
gram section of ileocecal lymph node, mesenteric lymph node, and pre-scapular lymph 
node was placed into sterile phosphate buffered saline (PBS) with antibiotic and 
antimycotic agents (penicillin, streptomycin, amphotericin B), and transported to the 
laboratory for lymph node cell collection, cell culture, and flow cytometric evaluation.  
Thirty milliliters (mL) of peripheral blood from each calf was obtained by jugular 
venipuncture, and aseptically collected into 2X acid citrate dextrose anticoagulant (2X 
ACD) for peripheral blood mononuclear cell (PBMC) culture, antigen stimulation, and 
flow cytometric analysis.   
     Histopathology and acid-fast staining.  Formalin-fixed paraffin-embedded tissues 
were sectioned (4m) and stained with hematoxylin and eosin (HE) for histopathologic 
evaluation and ZN acid fast staining per standard laboratory protocols.  All tissue sections 
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were examined thoroughly for evidence of mycobacterial infection both by identification 
of appropriate lesions (granulomatous inflammation) and presence of acid-fast bacteria. 
     Tissue processing for flow cytometry.  For PBMC‟s, the buffy coat was separated 
from whole blood, the remaining erythrocytes were lysed, and the PBMC were washed 
with PBS as previously described [14].  For lymph node-derived lymphocytes, fresh 
ICLN sections were minced, filtered through 7m mesh filter, and washed twice with 
PBS.  All cells were counted using a Becton-Dickinson (BD) Coulter counter (Becton-
Dickinson, Franklin Lakes, NJ), and diluted to 5 x 10
6
 cells/ml in culture medium.   
     Multi-parameter flow cytometry.  PBMC and lymphocytes from ICLN of each 
animal were activated as previously described [15], with minor alterations using Map K-
10 whole cell sonicate (WCS, 20 g/ml final dilution) as recall antigen.  Six fluorophores 
were used to simultaneously identify T lymphocyte subsets (CD4, CD8, and ), the 
activation marker CD25 (IL-2 receptor), and the intracellular cytokines interferon 
gamma (IFN and interleukin-4 (IL-4) as previously described [14].   
     Flow cytometric data collection and analysis.  Flow cytometric data were collected 
using a FACSCanto flow cytometer (Becton Dickinson Biosciences, San Jose, CA), and 
FlowJo cell analysis software (Tree Star Inc, San Carlos, CA) was used to analyze data.  
Expression index values were calculated to reflect the % gated positive events and mean 
fluorescence intensity (MFI) for each parameter from antigen stimulated samples as 
described earlier [14].  Index values for each parameter were then normalized to 
stimulated cells of the same tissue harvested from noninfected (negative control) calves at 
the same time point.  Using normalized values, Map-specific immune response locally 
(ICLN) was compared to the systemic (PBMC) response at each time by comparing 
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expression of CD25 and cytokine (IFN and IL-4) production by T cell subsets (CD4, 
CD8, and ).   
     Statistical analysis.  Statistical analysis was performed using JMP 8.0 (SAS Institute, 
Cary, NC).  Data are presented as the mean values ± standard error of the mean.  
Student‟s t-test and one-way analysis of variance were used for the statistical analysis.  
Group mean differences were considered significant if the p value was <0.05, and highly 
significant if the p value was <0.01.  Because multi-parameter flow cytometry data from 
low and high dose groups were collected on different days, it was not statistically valid to 
compare the two groups to each other due to significant daily variation inherent in these 
assays.  A single non-infected control animal was analyzed for each Map dosage group 
each day, so values for infected vs. non-infected animals could not be statistically 
compared.  Instead, animals were grouped into low dose (10
3
 and 10
5
 cfu) and high dose 
(10
7
 and 10
9
 cfu), and the data was normalized by subtracting values for the control 
animals from the values for the infected animals prior to statistical analysis.  We then 
compared local (ICLN) to systemic (PBMC) cellular immune responses within each T 
cell subset and dosage group each day after Map infection.   
 
Results 
     Post-surgical health status.  Calves demonstrated minimal post-surgical effects.  
Incisions healed normally and minimal soft tissue swelling of the incision site occurred in 
some calves, but these tissue changes resolved during healing.  No calf developed clinical 
signs of disease attributable to intestinal Map infection (diarrhea, weight loss or 
inappetence) during the study.   
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     Gross pathology.  Gross lesions uncommonly observed during the necropsy 
procedures were limited to fibrous adhesions between the omentum and the body wall at 
the surgical site.   
     Histopathology.  We examined ileocecal valve, ileum, spleen, liver, and lymph nodes 
from control and infected calves at each time point to identify significant microscopic 
pathology.  Tissue histopathology results are summarized by inoculation dose group (low 
dose=10
3
 and 10
5
 cfu, and high dose=10
7
 and 10
9
 cfu), and by day (PID 07-90).  
Significant histopathologic lesions were not identified in uninfected or low dose calves at 
any time point during the study.  Mild lymphofollicular hyperplasia of ileal Peyer‟s 
patches and lymph nodes as well as multifocal ileocecal crypt abscesses were present; 
however Map was not identified by culture or acid-fast staining in these calves.  
     In contrast, the high dose group calves had significant morphologic changes.  High 
dose calves had consistent granulomatous lesions in which acid-fast organisms were 
identified in the intestinal mucosa and draining lymph node.  As early as PID 07, 
intestinal tissues harvested from high dose calves had mucosal and submucosal 
macrophage aggregates containing acid-fast bacteria.  In one calf (#917) a focal 
submucosal pyogranuloma with central necrosis and large numbers of intracellular and 
extracellular acid-fast bacteria occurred at the site of Map injection.  At PID 07, 
multifocal and coalescing inflammatory cellular aggregates composed of macrophages, 
epithelioid macrophages, and occasional Langhans-type multinucleated giant cells were 
present within the intestinal submucosa (Fig. 1a) and ZN staining showed intralesional 
acid-fast bacteria (Fig. 1b).  By PID 60, inflammatory cells also extended into the lamina 
propria of villous tips of infected animals (Fig. 2a), and ZN staining revealed myriad 
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intracellular and extracellular acid-fast positive short bacterial rods in these areas (Fig. 
2b).  Low numbers of intracytoplasmic acid-fast organisms were also identified within 
macrophages in the draining (ileocecal) lymph node at PID 07, 30, and 90 (not shown).   
     Bacteriology.  We collected a complete set of tissues during necropsy, and feces 
weekly from each calf for Map culture and PCR to determine tissue colonization and 
fecal shedding.  Map culture was performed using the BACTEC system with IS900 PCR 
as a confirmatory test.  Tissue culture results were grouped by inoculation dose (low 
dose=10
3
 and 10
5
 cfu, and high dose=10
7
 and 10
9
 cfu), and by time after inoculation (PID 
07-90); the data are summarized in table 2.  All tissue and fecal samples from noninfected 
control calves were Map culture negative.  Map cultures from low dose calf tissues were 
sporadically positive while fecal cultures from this group were consistently negative 
throughout the study.  In contrast to low dose calves, live Map was detected in one or 
more tissues harvested at necropsy from all high dose calves (18/18).  A majority of 
calves in the high dose group had multiple tissues culture positive for Map (13/18).  Of 
high dose calf tissues, the ileocecal lymph node (16/18) and ileocecal valve (14/18) were 
most frequently Map culture positive while the pre-scapular lymph node (4/18) and 
spleen (4/18) were less frequently Map culture positive.  High dose calves also displayed 
intermittent Map shedding in fecal samples.  We recognize that a small percentage of the 
inoculum may have been inadvertently deposited into the intestinal lumen or the 
peritoneal cavity during intestinal Map inoculation.  As a result, culture positive feces 
acquired from experimentally infected animals during the first 2 days after inoculation 
(6/32) were interpreted to represent inoculum flow-through rather than active fecal 
shedding, and were thus excluded from the final analysis.  
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     Map-specific cell mediated immune responses (multi-parameter flow cytometry).  
The mean percentages of lymphocyte subsets (CD4, CD8,  and non-T cells) within 
unstimulated PBMC and ICLN cells from uninfected and Map-infected calves are shown 
in table 3. The lymphocyte subset profiles of each tissue at 6 days incubation were similar 
between infected and non-infected animals. The major difference was the  T cell 
population was high in PBMC but low in ICLN.  To evaluate Map-specific immune 
responses, we used immunofluorescence and flow cytometry to compare lymphocyte 
activation and cytokine secretion from PBMC (systemic) and ICLN (local) cells during 
recall assays.  Flow cytometry data were grouped by challenge dose (low, high), and 
evaluated within each day (PID 30-90).  In low dose calves, significant differences 
between local and systemic immune responses were limited to PID 60 and PID 90 (Fig. 
3).  Compared to PBMC, lymphocyte subsets from ICLN generated significantly greater 
amounts of Map-specific cytokines IFN (CD8 T cells at PID 60, Fig 3b; CD4 and  T 
cells at PID 90, Fig. 3e) and IL-4 (CD4 and  T cells at PID 90, Fig. 3f).  Overall in low 
dose calves, systemic immune responses to intestinal Map infection detected in PBMC 
remained significantly lower than local immune responses detected in ICLN throughout 
the study.   
     Significant differences between the local and systemic immune responses were 
detected as early as PID30 in high dose calves (Fig. 4).  Increased generation of Map-
specific IFN was detected in ICLN cells (CD4 T cells, Fig. 4b) at PID 30.  Though not 
statistically significant, ICLN CD8 T cells tended to generate more IFN and IL-4 at PID 
30 compared to PBMC CD8 T cells (Fig. 4b, c).  Peripheral blood-derived CD4 T cells 
123 
 
tended to generate elevated IFN and IL-4 at PID 60 and PID 90 compared to ICLN cells 
(Fig. 4e, f, h, i).  At PID 90, peripheral blood CD8 T cells generated significantly more 
IL-4 than ICLN CD8 T cells (Fig. 4i).  Overall in high dose calves (in contrast to low 
dose animals), systemic responses to intestinal Map infection were detected in PBMC 
during later time points (PID 60, PID 90) and did not remain significantly lower than 
local immune responses detected in ICLN. 
 
Discussion and conclusions 
     Difficulty in controlling Map-related disease in ruminants throughout the world is 
related to poor sensitivity and specificity of available diagnostic assays and the lack of 
completely protective vaccines [16].  Progress in improving diagnostic assays and 
vaccines is greatly hindered by challenges associated with the study of subclinical 
disease, when infected animals lack clinical signs, typical intestinal pathology, and 
definitive cellular or humoral evidence of their infection status [2, 16].  This gap in 
understanding the early immune response to Map infection in cattle underscores the need 
to develop models by which factors that shape the early response to Map and 
development of Map-associated disease can be clarified.   
     A wide range of oral dosages (10
3
-2.5x10
10 
live Map organisms) has been used in 
ruminant model studies with variable success [13, 17], and Hines et al recently suggested 
10
9
 live Map organisms be administered on each of two consecutive days for 
experimental studies in cattle [13].  We have used a novel approach to directly inoculate 
live Map into Peyer‟s patches of the ileocecal valve to successfully induce intestinal Map 
infection in young calves in a dose-dependent manner.  Unlike oral or intra-tonsillar 
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infection models [5, 13, 17], high dose calves consistently and rapidly developed 
characteristic intestinal lesions with intralesional acid-fast mycobacteria throughout the 
mucosa, ileal Peyer‟s patches, and draining lymph nodes.  In addition, Map was cultured 
from tissues of high dose animals, and these calves intermittently shed live Map in their 
feces.  Importantly, the morphologic and bacteriologic features identified in high dose 
calves in this study that mimic aspects of natural infection in the bovine have not been 
collectively demonstrated in an experimental Map intestinal infection model.   
     Dose-dependent responses (histology and bacteriology) are evident in our study.  We 
were unable to histologically demonstrate intestinal infection in low dose animals though 
up to 50% of these calves were tissue culture positive for Map at necropsy.  Mild 
intestinal inflammation and lymphofollicular hyperplasia of Peyer‟s patches and draining 
lymph nodes were observed in low dose calves, but were not significantly different from 
control calves.   
     The host immune response to Map infection has been studied locally during the 
clinical stages of Map infection or systemically using peripheral blood cells [3, 18, 19], 
but few studies have evaluated the local response during early or subclinical infection 
[20, 21].  The classic immunologic paradigm associated with mycobacterial disease is 
biphasic, and characterized by an initial T-helper 1 (Th1) response.  Effective Th1 
polarization mediated by IFN is considered to be integral for controlling mycobacterial 
infections [22], and detection of Map-specific IFN has been successfully utilized 
diagnostically during early stages of mycobacterial disease including Map infection in 
cattle [23].  Clinical Map infection in cattle is associated with a strong T-helper 2 (Th2) 
polarized response characterized by dominance of Th2 cytokines.  IL-4 and IL-5 play 
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roles in activation and proliferation of B lymphocytes, and subsequent immunoglobulin 
production which is prominent during clinical disease, and serves as the basis for 
commercially-available serum antibody diagnostic assays.  The shift from Th1 to Th2 
dominance of Map-associated disease has been well documented, yet the classic Th1/Th2 
paradigm may not be completely accurate in the bovine, and based on the work of several 
laboratories, a more complex interplay seems to be a more likely scenario [18, 24].   
     In the current study distinct immunologic profiles were evident in the low and high 
dose groups.  In general, Map-specific immune responses were strongest in the draining 
lymph nodes for the study duration in low dose Map-infected calves.  In the high dose 
Map-infected animals the local immune response dominated initially, but diminished in 
relation to the systemic response as the study progressed.  In both dose groups, we 
observed mixed Th1-like and Th2-like responses that were characterized by the 
production of both IFN and IL-4 from multiple lymphocyte subsets.  This response was 
identified sooner following inoculation in the high dose group.   Interpretation of the 
immunologic data is limited because of animal numbers and statistical power in this 
proof of principal study.  However we are intrigued by the dose-dependent responses 
observed in the draining lymph node and systemic circulation in our system.  Because 
they coincide temporally with tissue colonization, development of intestinal lesions, and 
active fecal shedding in high dose but not low dose calves, we believe the data provide 
preliminary clues regarding the evolution of the immunopathologic response during early 
intestinal Map infection in calves.  Given the complexity of host immune responses to 
mycobacterial pathogens [24, 25], our model affords a unique opportunity to analyze the 
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interplay of specific cellular subsets and cytokines occurring at the infection site and 
systemically during the initial stages of intestinal infection. 
     Other models have been successfully developed to study intestinal Map infection in 
cattle, and these systems offer invaluable opportunities to study the immunopathogenesis 
of Map-associated disease.  A ligated intestinal loop model with direct luminal Map 
inoculation has been used to elucidate mechanisms of initial intestinal invasion by Map 
and local host transcriptional events [12, 21].  Use of this model appears limited to the 
very early stages (hours) of infection, and the procedure requires prolonged surgical 
anesthesia of experimental animals.  A report by Allen et al describes the development of 
an ileal cannulation model in cattle to study the local and systemic immune response to 
Map in an oral challenge system [20].  Rare Map-infected macrophages were observed in 
the intestinal propria within 24 hours after oral infection, and Map DNA was identified 
using PCR in sequentially biopsied intestinal tissues; however significant differences in 
the activation status of intraepithelial lymphocytes of infected vs. uninfected animals 
were not demonstrated in the study [20].  The characteristic Map-induced lesions, acid-
fast organisms, or active fecal shedding of Map have not been observed in either the 
ligated intestinal loop or ileal cannulation models.  Regardless, a clear advantage of 
intestinal loop, ileal cannulation, and oral infection models is the ability to potentially 
investigate interactions of live Map with intestinal epithelia and/or M cells, which are 
proposed to play a significant but incompletely explored role in the pathogenesis of 
natural infection [26].  A unique and significant advantage of the experimental system 
reported here is that we have described a method to accelerate the pathogenesis of 
intestinal Map infection via direct delivery of a known infectious dose to the ileocecal 
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valve, the proposed natural infection site in young calves.  An objective of the current 
study was to develop a model resulting in consistent intestinal Map infection, and though 
this was successfully achieved, we did not observe classic lesions or clinical signs of 
naturally-occurring disease in cattle such as diffuse granulomatous enteritis leading to 
chronic diarrhea and emaciation.  Future work focusing on the disease progression of 
intestinal Map infection using this model should be performed; however a reliable model 
to study lesion development and immune responses during establishment of initial 
intestinal infection and progression of disease is important.  Given the current challenges 
associated with efficacious vaccination and accurate diagnosis of the subclinically 
infected animal, use of this model‟s unique features including granulomatous intestinal 
inflammation and intermittent fecal Map shedding is expected to prove useful for 
evaluation of novel vaccine candidates and/or diagnostic approaches in subclinically 
infected animals.  
     In conclusion, we have developed a reproducible model of intestinal Map infection in 
calves which shares important microbiologic, pathologic and immunologic features of 
natural Map infection in cattle, all within a short time period.  We believe the model has 
significant potential for not only expanding our understanding of the pathogenesis of 
Map-induced disease but also for identification of factors that influence the development 
of protective immune responses to infection. 
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Table 1 Experimental Design 
 
Table 1. Experimental  Design 
Dosage 
Group 
Map dose 
(cfu) 
Collection 
day 
No. of 
animals 
Low 1 x 10
3 
 PID 07 1 
PID 30 2 
PID 60 2 
PID 90 2 
1 x 10
5 
 PID 07 1 
PID 30 2 
PID 60 2 
PID 90 2 
Uninfected 
control 
PID 07 1 
PID 30 1 
PID 60 1 
PID 90 1 
High 1 x 10
7 
 PID 07 2 
PID 30 2 
PID 60 2 
PID 90 3 
1 x 10
9 
 PID 07 2 
PID 30 2 
PID 60 2 
PID 90 3 
Uninfected 
controls 
PID 07 1 
PID 30 1 
PID 60 1 
PID 90 1 
cfu = colony forming units; PID = post-infection day 
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Table 2 Tissue and fecal culture summary 
 
Table 2. Tissue and fecal culture summary 
Map dose Collection day Tissue positive Fecal positive 
Uninfected control PID 07 0/2 0/2 
 PID 30 0/2 0/2 
 PID 60 0/2 0/2 
 PID 90 0/2 0/2 
Low dose PID 07 2/2 0/2 
 PID 30 1/4 0/4 
 PID 60 1/4 0/4 
 PID 90 2/4 0/4 
High dose PID 07 4/4 0/4 
 PID 30 4/4 1/4 
 PID 60 4/4 4/4 
 PID 90 6/6 4/6 
Sample positivity was defined by BACTEC liquid culture system with confirmation by 
Map-specific IS900 sequence PCR. 
Low dose group = 10
3
 cfu and 10
5
 cfu; High dose group = 10
7
 cfu and 10
9
 cfu; PID = 
post-infection day 
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Table 3 Summary of % cell types in lymph nodes or peripheral blood 
 
Mean percentages of lymphocyte subsets (CD4+, CD8+, + and non-T cells) within 
unstimulated PBMC and ICLN cells harvested from uninfected control and Map infected 
calves are shown. 
ICLN = ileocecal lymph node; PBMC = peripheral blood mononuclear cells 
  
Table 3. Summary of % cell types in lymph nodes or peripheral blood 
  Mean % cell type 
Treatment Tissue CD4+ CD8+  Non-T 
Control ICLN 43 26.2 6.3 23.5 
Map infected  45.7 24.5 6.3 22.6 
Control PBMC 29.4 27.9 33.4 7.7 
Map infected  29.7 23.3 37.7 7.4 
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Figure 1 Small intestine, Map-infected calves, PID 07.  Panel 1a is an HE stained low 
magnification view of ileum near ileocecal valve where the submucosa is focally 
expanded by well demarcated aggregate of macrophages, multinucleated giant cells and 
fewer lymphocytes or neutrophils (arrows).  Panel 1b is a ZN acid-fast stained higher 
magnification view demonstrating the presence of acid fast bacilli in the submucosal 
granuloma.  A large cluster of bacteria is present within the cytoplasm of a giant cell 
(arrow); smaller aggregates of bacteria are present within macrophages (arrowheads).   
 
Figure 2 Small intestine, Map-infected calves, PID 60.  Panel 2a is an HE stained 
section of ileum near the ileocecal valve demonstrating the presence of epithelioid 
macrophages and Langhans-type multinucleated giant cells in a microvillus (arrow).  
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Panel 2b is a ZN acid-fast stained section showing intracellular and extracellular acid fast 
bacilli (arrow and inset) of a Map-infected calf at PID 60.   
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Figure 3 Immune responses in low dose Map-infected calves.  Flow cytometric 
detection of local (ICLN) vs. systemic (PBMC) immune responses in low dose calves are 
shown.  Net expression indices (mean +/- standard error of mean) of CD25, IFNand IL-
4 of ICLN and PBMC‟s from the low dose Map-infected calves are shown for each T cell 
subset.  EI=expression index, ICLN=ileocecal lymph node, PBMC=peripheral blood 
mononuclear cells, LPC=lymphocytes.  Significantly higher responses within the same T 
cell subset are indicated *p<0.05 and **p<0.01. 
  
138 
 
 
 
Figure 4 Immune responses in high dose Map-infected calves. Flow cytometric 
detection of local (ICLN) vs. systemic (PBMC) immune responses in high dose calves 
are shown.  Net expression indices (mean +/- standard error of mean) of CD25, IFNand 
IL-4 of ICLN and PBMC‟s from the low dose Map-infected calves are shown for each T 
cell subset.  EI=expression index, ICLN=ileocecal lymph node, PBMC=peripheral blood 
mononuclear cells, LPC=lymphocytes.  Significantly higher responses within the same T 
cell subset are indicated *p<0.05. 
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CHAPTER 5: GENERAL CONCLUSIONS 
           
 
 
     The central hypothesis for the set of studies discussed in this thesis dissertation has 
been that  T cells play a significant and central role at Map infection sites in young 
calves.  A longer-term goal of this work is to investigate and relate how these initial 
cellular and molecular events shape the ensuing adaptive immune response during Map 
infection, and ultimately how this may influence clearance, containment or progression of 
the disease.  A lack of data regarding systemic or local tissue immunopathology during 
early and subclinical disease periods underscores the challenges associated with accurate 
identification of subclinically infected individuals, and this ultimately affects our ability 
to control spread of this devastating disease.   
     The young calf is the model of choice to investigate this hypothesis, because they have 
abundant  T cells, are natural hosts for Map infection, and are normally infected with 
Map during the perinatal period.  Data generated from these studies supports our central 
hypothesis in two ways, namely that  T cell subsets 1) are differentially recruited to 
initial subcutaneous Map infection sites, and 2) have differential function at these sites.  
In addition, we are interested in applying these observations to the intestine to more fully 
understand the immunopathology of Map during natural disease, and we have made 
significant progress towards this goal by successfully developing an in vivo intestinal 
model of Map that mimics several features of natural disease.   
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Gamma-delta () T cell subsets are differentially associated with granuloma 
development and organization in a bovine model of mycobacterial disease 
      
     In Chapter 2, we set out to answer key questions regarding the role of bovine  T cell 
subsets during granuloma formation or maintenance during initial stages of Map 
infection, using a subcutaneous model developed by Simutis et al [1].  Though a number 
of reports have suggested distinct roles for human  T cell subsets during the anti-
mycobacterial immune response, a distinct role for  T cell subsets in the calf has not 
previously been investigated.  Considering the human and murine data in the literature, 
the hypothesis for this study was that bovine  T cell subsets, defined by their surface 
expression of the WC1 molecule, are differentially associated with the development of 
organized or unorganized granulomatous lesions at mycobacterial infection sites.  
Compared to unorganized Th2-like granulomatous lesions, highly organized Th1-like 
granulomas contained significantly more WC1+ cells during early stages and 
significantly more WC1- cells as the lesions became highly stratified and organized.  
Similar to a prior report by Wangoo et al [2], we demonstrated that as lesions stratify and 
organize over time, distinct spatial orientation of  T cell subsets becomes evident.  
Specifically, the WC1+ cells were restricted to the outer margins of the granuloma near 
the fibrous capsule while the WC1- cells were heavily concentrated near central regions 
of the granuloma adjacent to area of central caseation necrosis.  Finally, our data 
suggested distinct functional roles for  T cell subsets because we found that WC1- 
subset cells were preferentially recruited to early Map infection sites of naïve calves 
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while the WC1+ subset cells were more heavily recruited to early Map infection sites of 
antigen-sensitized (vaccinated) calves.   
     The study contributes towards understanding the immunopathology of the Map 
infection site in calves, suggests that  T cell subsets are involved with granuloma 
formation, and supports the hypothesis that  T cell subsets play distinct functional roles 
during the initial anti-mycobacterial host immune response, though these distinct roles 
remain to be completely defined.     
 
Evaluation of the initial host response to Mycobacterium avium subspecies 
paratuberculosis infection in sensitized and naïve calves using matrix biopolymers 
      
     In Chapter 3, we sought to expand our observations of the previous study by 
evaluating recruitment patterns of  and CD4+ T cells and cytokine production at the 
mycobacterial infection site of naïve or antigen-sensitized calves.  Our hypothesis for this 
study was that the differential recruitment of  T cell subsets (and CD4+ T cells) to early 
Map infection sites reflects their distinct functional roles during the developing immune 
response.  In the previous study, we were able to evaluate  T cell subsets within 
mycobacteria-induced lesions over time, but in that model the cells were difficult to 
recover for further phenotypic or functional analysis.  A goal for the second study was to 
modify the model so that recruited cells could be harvested and further evaluated ex vivo, 
and this goal was successfully met using the Matrigel biopolymer matrix.  A strong 
CD4+ T cell-mediated systemic immune response to Map vaccine [3] was also evidenced 
during this study by CD4+ T cell recruitment to late Matrigel Map infection sites of 
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vaccinated but not naïve calves.  In contrast,  T cells were recruited to early but not late 
Matrigel Map infection sites of all calves, supporting the hypothesis that  T cells have 
distinct roles during the early host immune response.  Others have evaluated responses of 
bovine peripheral blood-derived  T cells to mycobacterial antigens [4, 5]; our data 
expands these data by suggesting that in vivo  T cell recruitment to early Map infection 
sites is independent of previous Map antigen sensitization of calves.  We also found that 
 T cells harvested from Matrigel Map infection sites produced significantly more IFN 
at early compared to later times after infection.  We then demonstrated that bovine  T 
cell subsets have differential ability to generate IFN based on their expression of the 
WC1+ molecule.  Specifically WC1- but not WC1+ cells of naïve calves produced 
significant amounts of IFN after stimulation ex vivo, but this is apparently not antigen-
specific.  In contrast, WC1+ cells showed ability to generate IFN only if the host had 
previously been sensitized to Map antigen.  In summary for Chapter 3, our data supports 
the original hypothesis that bovine  T cells are not only differentially recruited to early 
Map infection sites, but also that these cells differentially secrete cytokines.  Given these 
features, our data supports the hypothesis that bovine  T cell subsets have distinct 
functions during different phases (innate response vs. memory response) of the anti-
mycobacterial immune response. 
 
Direct inoculation of Mycobacterium avium subspecies paratuberculosis into ileocecal 
Peyer’s patches results in colonization of the intestine in a calf model 
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     Considering our data from the prior two studies that suggests distinct functional roles 
for bovine  T cell subsets at early Map infection sites, the goal for project described in 
Chapter 4 was to develop a model where Map could be identified within granulomatous 
intestinal lesions in the young calf.  With the rationale that the submucosal Peyer‟s 
patches of the distal small intestine are the initial site of Map infection during natural 
disease of the calf, our hypothesis for this study was that direct delivery of an infectious 
dose of live Map into this location will result in rapid intestinal infection with pathologic 
and immunologic similarity to natural disease.  The development of Map-induced early 
intestinal lesions within current modeling systems has not been described [6] and as a 
result we are unable to directly test our infection-site hypotheses outlined in this 
dissertation.  We thus set out to develop a novel short-term experimental model in order 
to adequately address the unanswered questions relevant to immunopathogenesis of early 
intestinal Map infection.  Using this experimental inoculation model, we were 
successfully able to establish intestinal Map infection in calves.  This was verified by 
histology with Ziehl-Nielsen acid-fast staining, tissue and fecal culture and real-time 
polymerase chain reactions.  In addition, we evaluated Map-specific cell mediated 
immune response during early intestinal Map infection and found distinct differences 
between the local (ileocecal lymph node cells) and systemic (peripheral blood cells) 
response.  Specifically, we identified mixed Th1-like (IFN) and Th2-like (IL-4) 
responses of T cell subsets (CD4+, CD8+ and  T cells) occurring first in the ileocecal 
lymph node cells followed by similar responses in the peripheral blood cells of infected 
calves.  We described dose-dependent responses to intestinal Map infection both locally 
and systemically in this system.  Further, we showed that these immune responses 
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correlate temporally with the development of histologic intestinal lesions as well as the 
onset of intermittent fecal shedding of Map.  Obvious limitations of our model system 
exist, and the most prominent drawback is that it lacks the ability to investigate the role 
of the intestinal epithelial barrier during intestinal Map infection.  Regardless, use of our 
model provides for the first time a unique opportunity to analyze the development of the 
host immune response (including specific cellular subsets and cytokines) at the Map 
infection site in the distal small intestine during initial stages of the disease.  In summary, 
the results of these studies represent a significant step forward for understanding the 
pathogenesis of Map infection in cattle, particularly during the early and subclinical 
infection periods of disease which thus far has proved elusive in Map research.     
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Recommendations for Future Research 
 
 
     Mycobacterial diseases remain a major threat to animal and human health.  The 
epidemiologic range and incidence of Map and Map-associated disease of ruminants 
(Johne‟s disease) continue to expand in the US and around the globe [7].  The long 
asymptomatic subclinical infection period of this disease is a major contributing factor 
for continued knowledge gaps regarding the immunopathologic events and the evolving 
host immune response.  Understanding how the host immune system responds both 
locally and systemically during initial Map infection and how these initial events 
influence the ultimate disease outcome are expected to profoundly enhance our progress 
towards development of more successful diagnostic or vaccination strategies.    
     In the previous dissertation, we have approached these problems by utilizing a variety 
of unique animal modeling systems in the calf to answer important questions regarding 
the early Map infection-site immunopathologic response.  Our observations during these 
projects have supported our hypotheses that similar to humans, bovine  T cells readily 
respond to mycobacterial infection in vivo.  Based on these data, our ongoing hypothesis 
is that  T cells of calves have subset-specific responses to Map infection, and that these 
cells profoundly influence (at different phases) the ensuing anti-mycobacterial immune 
response.  Extending from this work are several distinct but overlapping avenues along 
which future effort should be directed.  
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Defining bovine  T cell subset ligands  
     We defined distinct patterns of recruitment of WC1+ and WC1-  T cell subsets to 
Map infection sites in naïve vs. antigen sensitized calves.  We also defined distinct in 
vivo and ex vivo responses by WC1+ and WC1- cells at Map infection sites.  While these 
data support our initial hypotheses, additional work to clarify the ligands recognized by 
 T cell subsets and the mechanisms by which responses are induced would be 
significant.  It appears that distinct differences between human and bovine  T cells, 
such as the failure of bovine naïve WC1+ cells to recognize the prototypical human V2+ 
ligand phosphoantigens [5], would preclude the use of cattle as an appropriate model for 
human  T cell immunobiology.  However, ligands for human  T cells continue to be 
described, and specific ligands for bovine  T cells have only briefly been investigated.  
Our data coupled with the known tissue distribution of bovine  T cell subsets [8] would 
support a hypothesis that WC1- cells function predominantly in immune surveillance and 
innate responses while the WC1+ cells function more in memory recall responses during 
subsequent infections.  To investigate this hypothesis, it will be important to characterize 
each subset of bovine  T cells by screening for reactivity of the cells toward potential 
ligands at varying stages of disease.   
 
Defining the cytotoxicity of bovine  T cell subsets 
     In humans, broad cytotoxicity has been reported for both V1+ and V2+ cells [9] and 
these mechanisms can be mediated by either the Fas/Fas ligand pathway [10] or the 
perforin/granzyme pathway [11].  The cytotoxicity of  T cell subsets in cattle has not 
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been fully characterized, though a natural cytotoxicity receptor (NKp46) is expressed on 
the surface of WC1- cells during specific in vitro conditions [12].  Based on our data that 
WC1- cells of cattle are preferentially recruited to Map infection sites of naïve calves, in 
vivo cytotoxic activity against mycobacteria by WC1- cells seems to be a reasonable 
hypothesis.  Testing this hypothesis by demonstrating in vivo cytotoxicity of WC1- cells 
at Map infection sites in calves is important, and could potentially be a mechanism to 
target in order to reduce the viability of extracellular and intracellular mycobacteria.  This 
mechanism could also be important for limiting progression of Map during the very 
initial stages of infection.     
 
Defining interactions of bovine  T cell subsets with macrophages 
     We have shown that  T cells are rapidly recruited to early Map infection sites of 
cattle.  Though we have documented that specific subsets of these cells display distinct 
recruitment patterns (WC1- in naïve calves, WC1+ in Map antigen-sensitized calves), we 
have observed that both subsets have ability to generate IFN, albeit in distinctly different 
scenarios.  Specifically, WC1- cells from both naïve and antigen-sensitized calves 
generate significant amounts of IFN while WC1+ cells from antigen-sensitized calves 
but not naïve calves generate increased IFN.  Given this data, further investigation of the 
interactions of WC1- cells with Map-infected macrophages at the initial infection site is 
important.  Simutis et al previously showed the failure of peripheral blood-derived  T 
cells from sensitized cattle to induce macrophage killing of Map in a co-culture system 
[13].  In that study however, the WC1 phenotype of the cells was not reported and 
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because they were harvested from peripheral blood compartment of young calves, it is 
reasonable to assume that most were WC1+.  It would be very interesting to use a similar 
co-culture system to investigate the potential of purified  T cell subsets from both naïve 
and antigen-sensitized animals to affect macrophage killing of Map.  The Matrigel 
system outlined in this dissertation could also potentially be adapted to investigate the 
role of  T cell subsets to induce macrophage killing of Map at Matrigel Map infection 
sites in vivo. 
 
Defining interactions of bovine  T cell subsets with DCs 
     The key to clearance or at least containment of mycobacterial infection appears to be 
the development of an appropriate CD4+ T cell mediated response.  It has recently 
become clear that the DC is the single most important cell for antigen presentation to 
naïve T cells, thus DCs play a primary role for initiation of effective cell-mediated 
immunity.  For these reasons, the role that  T cells play in enhancing DC maturation 
and antigen presentation could potentially be a mechanism for stimulation of more 
efficacious responses.  As previously mentioned, the high prevalence of  T cells in 
young individuals has been proposed as a mechanism mediating improved vaccine 
efficacy compared to adults [14].  The mechanistic interactions between  T cell subsets 
of cattle with DCs should be investigated.  Data from our lab has demonstrated that DCs 
harvested from Map infection sites of calves are phenotypically and functionally 
impaired [15].  Enhancing initial antigen presentation by stimulating infection site DCs 
using activated  T cells during Map infection could improve DC maturation, antigen 
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presentation and ultimately enhance development of protective CD4+ T cell mediated 
immunity.  Several approaches could be utilized to test this hypothesis.  First, a co-
culture system could be developed to evaluate in vitro the ability of  T cell subsets to 
effect the maturation of Map-infected DCs.  If this could be further clarified, the Matrigel 
system could then be adapted to test similar hypotheses in vivo.  Ultimately, 
understanding the  T cell-DC interactions and the effects on development of the 
downstream adaptive immunity could potentially have profound effects on future vaccine 
development for a variety of intracellular infections of humans and animals [16].     
 
Investigation of IL-17 production by bovine  T cell subsets 
     The role of IL-17 during inflammatory pathology and autoimmune diseases at 
mucosal sites is well described in mice and humans [17].  Similar data in cattle has not 
been described.  Given the profound effects of IL-17 on these processes, it seems 
reasonable to hypothesize that like humans and mice, bovine  T cell subsets also 
produce IL-17 in certain scenarios and this should be investigated.  Studies using either 
ex vivo culture systems or the in vivo Matrigel Map infection system could be utilized to 
investigate this hypothesis.  It would be intriguing to evaluate the potential role for  T 
cells and the IL-17 axis during key transition points of intestinal Map infection (ie, 
development of lesions and establishment of an infection nidus or during the subclinical 
to clinical phase transition), as strong Th17 responses have been described during chronic 
inflammatory bowel disease of humans [18].   
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Investigation of bovine  T cell subsets to process and present antigen in vivo 
     Over ten years ago it was demonstrated that antigens can be taken up by bovine WC1+ 
 T cells and presented to CD4+ T cells [19], and more recently it has been shown that 
human V2+  T cells have similar capacity [20, 21].  It has been hypothesized that 
antigen presentation by cattle and human  T cells is restricted to inflammatory settings 
because resting  T cells of both species lack antigen presentation capabilities [21].  We 
have demonstrated that  T cell subsets differentially respond to mycobacteria by 
migrating to and generating cytokines at early Map infection sites in the calf, yet the on-
going hypothesis that  T cell subsets influence the adaptive immune response by 
modulation of DCs or  T cells remains to be fully explored.  The ability to investigate 
functionality of  T cell subsets in vivo at the initial mycobacteria-induced infection and 
inflammation site represents a unique opportunity to explore the full biological potential 
of these cells, and use of this model to study these interactions should be pursued.   
 
Translation of bovine  T cell function to the intestinal Map model 
     Ultimately how the data presented in this thesis dissertation relate to Johne‟s disease 
in cattle will depend on elucidation of  T cell-mediated immune mechanisms at the 
level of the intestine.  The calf model of localized subcutaneous Map infection has 
distinct advantages for in vivo study of  T cell immunobiology and as such provides a 
much needed “window to an infection site,” yet in order to understand the full biologic 
significance of these findings as they relate to Johne‟s disease, an intestinal model should 
prove valuable.  As a result, the development of a model which results in consistent 
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intestinal colonization by Map (described in Chapter 4), represents a significant step 
forward.  Filling significant knowledge gaps regarding the immunopathology of early and 
subclinical Map infection in cattle greatly enhances our ability to address the 
considerable challenges associated with prevention and diagnosis of Johne‟s disease 
within the cattle industry.  For example, a major factor leading to spread of Map within 
and between herds is the inability to accurately diagnose subclinically-infected animals 
[22].  Understanding the “immunologic footprint” during early vs. subclinical vs. clinical 
Johne‟s disease, for example, allows for the improvement of current tests or the 
development of new diagnostic testing strategies for this disease at various stages of 
disease.        
     In conclusion, future studies should thus focus on two distinct but interconnected 
areas: 1) understanding the in vivo role of  T cells in shaping the cell-mediated immune 
response to Map, and 2) applying these data to the intestinal immunopathology of Map 
infection.  Taken together, these studies are expected to continue to shed considerable 
light on the pathogenesis of Map infection in cattle.   
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